Академический Документы
Профессиональный Документы
Культура Документы
The DBS Asian Insights SparX report is a deep dive look into thematic angles impacting
the longer term investment thesis for a sector, country or the region. We view this as an
ongoing conversation rather than a one off treatise on the topic, and invite feedback
from our readers, and in particular welcome follow on questions worthy of closer
examination.
Table of Contents
Summary 3
How much dairy is China consuming? 5
Trends and opportunities 8
Dairy supply chain & sustainability 19
I) Dairy farms 20
II) Downstream processors 26
III) Infant formula 32
Stock Profiles 38
China Mengniu Dairy (2319 HK) 38
Bright Dairy (600597 CH) 46
China Modern Dairy (1117 HK) 53
Inner Mongolia Yili (600887 CH) 60
H & H International (1112 HK) 64
Yashili International (1230 HK) 67
Appendix 71
Summary
Yogurt sales leading growth. China’s dairy sales, inclusive of consumer trade-up and population growth. In terms of
alternative milk, could post a healthy 5.3% CAGR in 2016- product category, yogurt (UHT yogurt, pro-biotic beverages),
2021F according to Euromonitor, driven by rising yogurt cheese and butter should continue to see a double-digit
demand (15.6% CAGR). UHT yogurt, in particular, should CAGR in the range of 10.2-15.6% for 2016-2021F (source:
post the fastest growth of >20% CAGR, as many Chinese Euromonitor), which should offset softening sales in basic
consumers are lactose intolerant and avoid milk. This UHT milk and flavoured milk beverages. While c.50% y-o-y
category does not need to be stored at low temperatures, rise in the prices of whole-milk powder (WMP) as well as
allowing it to swiftly expand into more remote areas across increases in sugar and packaging costs could lay pressure on
China. Other products like cheese, butter and plant-based gross margins, a cut in advertising and promotional
milk (e.g. walnut milk, coconut milk, soy milk, etc.) also see spending post 2016 Olympics should offset rising raw-
increasing customer demand. Some players are also looking material costs.
for new opportunities in e.g. organic products, goat milk,
IMF to resume growth. The infant milk formula (IMF)
etc. to tap the high-end segment.
segment has been affected by more stringent regulations
Globalisation is prompting more M&As. As households’ and players need to meet registration requirements before
purchasing power continues to improve and Mainland 2018. Volume growth should resume this year on the back
Chinese travel more, consumers are trading up and of the revised tax regime for purchases via cross-border e-
demanding better quality and varieties, including an commerce. Euromonitor also projects the IMF segment to
increasing amount of imported products. Diversification grow at 6% CAGR in 2016-2021F, along with relaxation of
strategies on products, brands and distribution channels, as the One Child Policy and rising demand for higher quality
well as gradual premiumisation will be required to cater to brands. The Development Plan for China Milk Industry
changing consumer behaviour. As a classic example, Nestlé (2016-2020) promotes market consolidation, targeting
has evolved over time, from initially selling infant and dairy >80% domestic IMF sales to come from Top-10 players in
products to also offering ice-cream, beverages, nutritional China by 2020E. Better performance could be achievable by
products, pet foods, confectionery, etc, through M&As. It large players as the market firms up.
has also seen its share price surge over 14 times in the last
Stock picks. To conclude, we prefer downstream operators
30 years, reaffirming the strong potential of well-executed
with financial ability to develop an integrated supply chain.
acquisitions. As non-dairy companies continue to enter the
We expect profitability to continue to aggregate at the mid-
dairy & plant-based segments – an example is soft-drink
downstream supply chain, thanks to cheaper dairy imports.
leader Coca-Cola, tapping the US premium-milk category
Among listed players, our top picks are China Mengniu
through a JV with Fairlife to produce milk with higher
(2319.HK) and Bright Dairy (600597.CH). While we do not
protein and no lactose, and spending US$575m on
cover Inner Mongolia Yili (600887.CH), as a leading player it
Unilever’s AdeS soy brand in Latin America - Chinese dairy
should also benefit from a growing dairy industry and M&A
groups should also speed up M&As to lift product quality
opportunities.
and variety.
China Mengniu (2319.HK, BUY). We like Mengniu as one of
Upstream faces pressure from imports. Since 2008’s
the leading PRC liquid milk operators. Despite being seen as
melamine scandal, China’s dairy supply chain has been
a laggard to the largest peer Yili in both market share and
heavily scrutinised and hampered by stringent government
profitability, we believe Mengniu has room for improvement.
policies. While significant improvement has been made
We also expect its yogurt sales to maintain double-digit
along the supply chain, we believe there is further room for
growth, driven by new SKUs. Maintain BUY with TP of
enhancement especially in food safety and cost
HK$18.8/sh.
competitiveness. Specifically, upstream players’ profitability
is determined by raw milk prices, feed costs, productivity Bright Dairy (600597.CH; Upgrade to BUY). Bright Dairy
and overall efficiency. With a growing supply of low-price has been a laggard to Mengniu and Yili in the past couple
imported milk powder, it seems difficult to see an inflection of years, due to market share losses and failure to inject
point in the PRC upstream sector. Further support by the Israeli Tnuva from its parent company amid unfavourable
downstream brand operators in the form of guaranteed market conditions. We believe Bright Dairy remains a key
volume commitment, capital investment or financial support beneficiary as consumers shift from UHT milk to fresh
may be required to help sustain upstream profitability. products including “Bright” and “U+”. Bright Dairy is now
trading at 25x FY18F PE, which is c.1.5 S.D below its 5-year
Downstream to see more catalysts. The downstream
trading average. Upgrade to BUY with TP of RMB14.20/sh,
segment has seen strong topline and earnings growth,
based on SOTP valuation.
supported by rising dairy consumption per capita thanks to
Peers valuation
Infa nt Formula
Yashili International 1230 HK HKD 1.42 n.a. NR 861 n.a. n.a. 72.6 0.2 0.5 1.0 1.0 (0.3) 1.3
H & H Intl. Hdg. 1112 HK HKD 23.9 n.a. NR 1,934 13.6 17.3 14.9 0.1 0.4 3.2 2.6 20.7 19.2
Beingmate Baby 'A' 002570 CH CNY 11.97 n.a. NR 1,801 n.a. 292.0 88.0 0.1 0.2 4.1 4.0 1.6 4.4
Ave ra ge 13.6 154.6 58.5 0.1 0.4 2.8 2.5 7.3 8.3
Da iry Fa rm
China Modern Dairy* 1117 HK HKD 1.48 1.52 HOLD 1,160 n.a. n.a. 93.0 0.0 0.0 1.2 1.2 (9.7) 1.3
Yuanshengtai Dairy Farm 1431 HK HKD 0.4 n.a. NR 240 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
China Zhongdi Diary 1492 HK HKD 0.83 n.a. NR 231 13.6 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a.
China Shengmu Orgc.Milk 1432 HK HKD 1.47 n.a. NR 1,196 11.8 9.5 7.5 0.0 0.0 1.1 0.9 12.8 13.5
Ave ra ge 12.7 9.5 50.2 0.0 0.0 1.2 1.1 1.5 7.4
2008
2009
2010
2011
2012
2013
2014
2015
2016
Volume % y-o-y
33 .2kg
2 6 .2kg Source: NBS, DBS Vickers
Dairy consumption per capita by country (2016) Urban vs. Rural household disposable income
Thailand
China
Denmark
South Korea
UK
Mexico
France
Brazil
Japan
NZ
US
2009
2010
2011
2012
2013
2014
2015E
2016E
2017E
2018E
Taiwan
Urban Rural
Source: OECD, DBS Vickers Source: Frost & Sullivan, DBS Vickers
Domestic production is declining… Two Child Policy - positive. Since the relaxation of One
Child Policy in Oct’15, there were an additional 1.31m births
At present, China is the fourth-largest dairy producer in 2016 versus a year ago. While 17.86m babies born had
globally after USA, the EU-28, and India. Nevertheless, raw just missed the original target of 18m births for 2016, the
milk production declined at a CAGR of 1.7% in 2014-16 on impact on demand for infant milk formula should be
the back of a surge in imports. In 2016, China production positive.
declined 4.1% y-o-y to 36m tons. In terms of dairy-related
Based on our estimates, we predict around c.7% net
products, production grew at a CAGR of 3% y-o-y to 38.7m
increase in birth rates for 2017F, supported by organic
tons.
growth of 0.5% y-o-y, and the relaxation of the One Child
Policy.
Birth rates
15
10
0
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017F
m tonne
1.6
1.4
Source: JD.com, DBS Vickers
1.2
1.0
What is milk powder used for? Based on our conversation
0.8 with dairy processors, milk powder can be conveniently
0.6 converted into UHT milk (reconstituted), milk beverages,
0.4 yogurt, and ice-cream. Based on USDA publication, the
whole milk powder (WMP) is typically used for infant
0.2
formula (25% of total share), fluid milk (30%), milk
0.0
beverage (20%) and bakery products (25%). In 2013-14,
2012 2013 2014 2015 2016
due to a fear of milk powder shortage, dairy imports as %
Fresh milk Milk powder Yogurt Butter Cheese of domestic production surged to 21-23%, thereafter
normalised to 13-15% in 2015-16. We expect dairy imports
Source: China Customs, DBS Vickers could see further room to stage proportionate expansion.
Import volume – milk powder Imported milk powder breakdown % (by origin)
MT %
100% 3.9 2.7
180,000 140 5.4 4.9 4.4
160,000 120 90% 3.6 8.7
8.4 8.7
140,000 100 80%
80
120,000 60 70%
100,000 40 60%
80,000 20 50%
60,000 0
40% 78.9 81.8 83.3
(20)
40,000 (40) 30%
20,000 (60) 20%
0 (80)
10%
May-14
May-15
May-16
May-17
Nov-14
Nov-15
Nov-16
Feb-14
Feb-15
Feb-16
Feb-17
Aug-14
Aug-15
Aug-16
0%
2014 2015 2016
Milk powder % y-o-y New Zealand EU28 Australia USA Others
Imported milk powder vs. PRC dairy production volume Import volume – liquid milk
25% MT %
80,000 300
20% 70,000 250
60,000 200
50,000
15% 150
40,000
100
23% 30,000
10% 21% 50
20,000
15% 15% 10,000 0
13%
5% 0 (50)
Oct-13
Feb-14
Oct-14
Feb-15
Oct-15
Feb-16
Oct-16
Feb-17
Jun-13
Jun-14
Jun-15
Jun-16
0%
2012 2013 2014 2015 2016 Liquid milk % y-o-y
USD bn
120 2011-16 CAGR: 7.3% 7% Average selling price of yogurt in China (RMB/kg)
2016-21 CAGR: 5.3%
100 6%
RMB
5% 15
80
4%
60 14
3% R
40 13
2%
20 1% 12
0% 11
2016 2017F 2018F 2019F 2020F 2021F
Total Dairy& Alternative Milk (LHS) 10
YoY Growth (RHS)
9
Source: Euromonitor 8
2010 2011 2012 2013 2014 2015 2016 2017
Meanwhile, there are a few types of dairy products that Source: Wind
have minimal effects on consumers with lactose-intolerance.
They include aged cheese (e.g. cheddar, parmesan, etc.), Looking at the key growth segments across China dairy (&
butter, as well as Yogurt (probiotic or full-fat yogurt). Others alternative milk), Euromonitor projects both cheese and
like plant-based milk such as walnut milk, coconut milk, soy yogurt to see strongest demand, staging the fastest growth
milk, etc. could also be the alternatives. Hence, there is of 15.6% and 14.1% CAGR respectively in 2016-2021F.
increasing customer preference for these products in China. These are followed by a 10.2% CAGR for butter and
margarine.
In terms of market share, yogurt products could see the
Sound demand for yogurt. At present, the penetration rate
most gain of 16ppt during 2011-2021F to attain a 27.5%
of yogurt products in China in terms of per capita
share of the PRC dairy market by 2021F. The expansion
consumption remains low. As demand increase further
mainly comes at the expense of flavoured milk drinks that
while household affordability also improves, the average
could see c.14ppts squeeze in market share, to 5.3% by
selling price (ASP) of yogurt could also see room to increase
2021F.
ahead, as seen from a fairly steady ASP increase since 2010,
equivalent to >5% CAGR.
CA G R CA G R
RMB bn
(2011-2016) (2 0 1 6 - 2 1 F ) 14
Cheese 20.8% 15.6%
12
Yogurt Products 18.4% 14.1%
10
Butter and Margarine 9.3% 10.2%
Milk F ormula 12.1% 6.0% 8
Milk Alternativ es (plant-based) 4.6% 3.9% 6
Milk 5.6% 3.5% 4
Ice Cream and F rozen Desserts 2.1% 2.0%
2
F lav oured Milk Drinks -0.9% -11.7%
T o t al dairy & alt ern at iv e milk 7.3% 5.3%
2009 2010 2011 2012 2013 2014 2015 2016
Source: Euromonitor Top 3 Premium Milk Brand Sales
Other Premium Milk Sales (Estimated)
Non-Premium Milk Sales
Others 250
200
Source: Euromonitor
150
100
50
0
2008 2009 2010 2011 2012 2013 2014 2015 2016
Source: Euromonitor
Fresh milk may see accelerated demand ahead. At present, More attractive growth of yogurt vs liquid milk
Bright is the leading player in the fresh milk segment. Its
own "Bright" brand and "U Best" brand took up 7% and RMB bn %
5.9% market share respectively in 2016, adding up to a 600 30
total of 12.9% share.
500 20
Certain entry barriers exist though, which include the
400 10
upstream support in terms of raw milk sources and quality,
plus cold-chain logistics infrastructure. All these could result 300 0
in the top fresh milk players still mainly comprise of 200 (10)
domestic operators. With the increase in consumer
awareness on nutritive value of fresh milk and gradually 100 (20)
improving cold-chain logistics, more of such products from (30)
domestic suppliers as well as imported fresh milk could be
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
demanded in China.
Milk Yogurt
PRC: Top-10 brands in fresh milk
Source: Euromonitor
T op 10 M ark et
Co mp an y N ame
B ran d N ame Sh are
Bright Dairy 12.9 Specifically, among all yogurt products, plain yogurt that
(Bright Bright F ood (Group) Co Ltd 7.0) largely consists of ambient (UHT) yogurt product currently
(U Best Bright F ood (Group) Co Ltd 5.9) has a lower base, potentially posting 21% CAGR in 2016-
Sany uan Beijing San Yuan F oods Co Ltd 10.3 2021F and take up a majority of the yogurt market in China
Weigang Nanjing Dairy (Group) Co Ltd 5.3 (source: Euromonitor).
J ia Bao J iabao Group Co 4.2
Huangshi Guangxi Roy al Dairy Co Ltd 3.3
In China, there is a rising number of consumers eating
Chenguang Shenzhen Guangming Group Co Ltd 1.8
yogurt products during breakfast, or starting to use them in
F low er Canton A merican F low er Lounge 1.8 salad dressings. UHT yogurt, in particular, does not need to
Huaxi Sichuan New Hope A gribusiness Co Ltd 1.3 be stored at lower temperatures so that consumers can
Yinqiao China Dairy Group Ltd 1.2 carry it around easily. It can also expand to the more remote
T op 10 29.2 areas for sale given that it does not require cold-chain
transportation or storage.
Source: Euromonitor
Market share of Top-5 plain yogurt brands in China 2016 retail value RSP of Top-20 Plain yogurt brands in
China
2010 2016
T o p 2 0 Plain 2016
Top 5 Y o g u rt B ran d Co mp an y N ame Sales
Brands Others
N ame ( R M B m)
37% 24%
A mbrosial Inner Mongolia Yili Industrial 11,524.8
Group Co Ltd
Mengniu China Mengniu Dairy Co Ltd 9,373.6
Momchilov tsi Bright F ood (Group) Co Ltd 6,330.1
Yili Inner Mongolia Yili Industrial 1,980.9
Group Co Ltd
A B 100 Bright F ood (Group) Co Ltd 692.2
Weigang Nanjing Dairy (Group) Co Ltd 656.0
Others Top 5 J un Le Bao China Mengniu Dairy Co Ltd 628.0
63% Brands
76% J ia Bao J iabao Group Co 613.7
Sany uan Beijing San Yuan F oods Co Ltd 592.7
A ctiv ia Danone, Groupe 459.2
Wonder Sun Wonder Sun Dairy Co Ltd 254.6
Bright Bright F ood (Group) Co Ltd 220.5
Tiany ou Sichuan New Hope A gribusiness 99.4
Co Ltd
Rushi Bright F ood (Group) Co Ltd 63.4
Huaxi Sichuan New Hope A gribusiness 45.5
Co Ltd
Yinqiao China Dairy Group Ltd 44.4
F low er Lounge Canton A merican F low er Lounge 36.5
Liv estock Co Ltd
Yantang Guangzhou Yantang Dairy Co 33.6
Ltd
Classy Kiss Green's Bioengineering 18.4
Source: Euromonitor, companies (Shenzhen) Co Ltd
F engxing Guangzhou F engxing Dairy Co 17.9
Ltd
Source: Euromonitor
RMB bn
80,000 2016-2021E CAGR: 3.9%
70,000
60,000
50,000
40,000
Source: Companies 30,000
20,000
iii) Dairy alternatives: plant-based milk products 10,000
0
In developed regions such as the US and Europe, per-capita 2016 2017F 2018F 2019F 2020F 2021F
consumption of dairy milk fell by 13% and 4%, respectively,
over 2011-2015, as consumers become more conscious Source: Euromonitor
about health and wellness while there are also increasing
controversy about saturated fats in cow’s milk being the
primary cause of heart disease.
Plant-based milk market in China
We have seen rising consumer interest in plant-based milk
produced from soy, walnut, coconut, almond, peanut, rice,
oat, etc. With soy milk being the traditional plant-based 2010
drink, during recent years there are also demand shifts from
cow’s milk towards other types of alternative milk in China.
2012
While Euromonitor’s projected 2016-2021F CAGR of 4% in
the plant-based category denotes a mild growth, we find 2014
certain flavours, such as soy, has been growing strongly. For
example, market leader Vitasoy has been reporting double-
2016
digit CAGR in the past 3-4 years with solid expansion into
e.g. Wuhan. New comers, such as Dali Foods, Want Want
0% 20% 40% 60% 80% 100%
have also entered this category.
Soy (e.g. Vitasoy) Walnut (e.g. Six Walnut)
Coconut (e.g. Coconut Palm) Peanut (e.g. Yinlu)
Almond (e.g. Lolo) Others
Source: Euromonitor
M ilk and milk alt ernat iv es: Nut rit ion c omparison per 8 f luid ounc es
Cat egory (per 8 f luid ounc es) Calories Carbohy drat es (t ot al) Sugars F at (t ot al) Prot ein
Cow's milk (whole) 150 12 g 12 g 8g 8g
Cow's milk (1%) 110 12 g 12 g 2g 8g
Cow's milk (skim) 80 12 g 12 g 0g 8g
Almond milk (unsweetened) 40 1g 0g 3g 2g
Soy milk (unsweetened) 80 4g 1g 4g 7g
Rice milk (unsweetened) 120 22 g 10 g 2g 0g
Coconut milk bev erage (unsweetened) 50 2g 0g 5g 0g
JD
Newer domestic distribution channels. Following the rising
popularity of e-commerce in China, plus strong demand for Tmall
overseas foods & beverages amid lingering concerns about Yi Hao Dian
food safety, we have seen a substantial increase in the
Su Ning
online sales of dairy products. Such demand has been
expedited via “daigou” services that are made available by GOME
online agents, as well as the roll-out of free-trade zones and
Wo Mai Wang
cross-border e-commerce channels in the PRC. Hence, the
proportion of online dairy sales surged from <1% in 2010 Dang Dang
to 8% in 2016, particularly driven by strong demand of Amazon
imported dairy items such as infant milk formula (“IMF”)
products. 0% 10% 20% 30% 40% 50%
Sales Amount Sales Volume
Seasonality of online dairy sales UHT yogurt last year. As e-commerce and overall logistics
infrastructure develop across China, we expect the online
RMB bn Single's Day % channel to increase in importance for the overall dairy
Promotion market.
JD Anniversary (Nov 11th)
2.7
Promotion (Jun 18th)
3.0 200
2.5 1.7
150
2.0
100
1.5
50
1.0
0.5 0
0.0 (50)
May-16
Feb-16
Oct-16
Mar-16
Apr-16
Sep-16
Jan-16
Aug-16
Jun-16
Jul-16
Nov-16
Source: Syntun
Imported Milk
High-end milk
Liquid
Room temperature milk Baby
yogurt 31%
Flavor milk
Infant
Ordinary pure milk powder
69%
Function milk
Children's milk
Low temperature
milk
0% 50% 100%
0% 5% 10% 15%
Source: Syntun
Nu t rit io n & M ed ic al
M&A 26-05-00 Summit Technology Inc/MA 839 U.S. Cash
M&A 19-06-06 J enny Craig Inc 600 U.S. Cash
M&A 14-12-06 Medical nutrition business 2,500 Switzerland Cash
M&A 11-02-14 Galderma Pharma SA 4,272 Switzerland Stock
M&A 28-05-14 Aesthetic dermatology assets 1,400 U.S. Cash
Ic e Cream
M&A 09-12-96 Ault ice cream div ision 163 Canada Cash
M&A 26-12-01 Ice Cream Partners USA LLC 641 U.S. Cash
M&A 17-06-02 Drey er's Grand Ice Cream Holdings Inc 2,595 U.S. Cash
M&A 23-01-03 Moev enpick ice cream business N/A Switzerland Undisclosed
M&A 24-05-04 V aliojaatelo ice cream business N/A F inland Undisclosed
M&A 19-12-05 Delta Ice Cream SA 288 Greece Undisclosed
B ab y F o o d
M&A 12-04-07 Gerber Baby F oods 5,500 U.S. Cash
M&A 23-04-12 Pfizer Nutrition 11,850 U.S. Cash
R ead y F o o d
M&A 28-04-88 Buitoni SA 1,100 F rance Cash and Stock
M&A 06-08-02 Chef America Inc 2,600 U.S. Cash
M&A 05-01-10 North American pizza business 3,700 U.S. Cash
M&A 04-02-16 Osem Inv estments Ltd 849 Israel Cash
Can d y
M&A 23-05-06 Uncle Toby s Unit 673 Australia Cash
M&A 11-07-11 Hsu F u Chi International Ltd 1,519 China Cash
Dairy
M&A 17-08-94 Av idesa, Miko & Castillo de Marcilla N/A Spain Undisclosed
M&A 31-01-02 Brand + Yogurt facility 205 U.K. Cash
M&A 18-11-05 Sv enska Glasskiosken AB N/A Sweden Undisclosed
M&A 18-04-11 Yinlu F oods Group N/A China Undisclosed
Pet F o o d
M&A 04-02-98 Spillers Petfoods 1,185 U.S. Cash
M&A 16-01-01 Nestle Purina PetCare Co 11,856 U.S. Cash
USD
100
90
i j
80
70 h
60 f
50 d e g
40
a b
30 c
20
10
0
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
A n n o u n c emen t A c q u ired Co mp an y T ran sac t io n V alu e Pay men t T y p e EV /EB IT DA
T ime ( US$ m) (x)
CHF m CHF m %
20,000 120,000 20
18,000 18
16,000 100,000
16
14,000 80,000 14
12,000 12
10,000 60,000 10
8,000 8
6,000 40,000
6
4,000 20,000 4
2,000 2
0 0 0
2018F
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
2010
2012
2014
2016
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
2010
2012
2014
2016
EBIT (LHS) EBITDA (LHS) Revenue (RHS) EBIT Margin EBITDA Margin
House brand
I) Dairy farms
The dairy farming sector has witnessed significant changes Dairy production volume (tonne/annum)
along with the rise of large-scale commercial farming.
Tighter government policies and the introduction of private Co mp an y 2016 %
financing etc. have all expedited the process. We estimate China Modern Dairy 1,009,854 2.8%
farm size contribution with <100 heads to drop from 57% Shengmu 598,379 1.7%
in 2009 to 37% in 2019F, while those with >1,000 heads Bright Dairy * 350,000 1.0%
will expand from 3% in 2009 to 10% by 2019F. J apfa 372,500 1.0%
Zhongdi Dairy 224,094 0.6%
Dairy farm size breakdown YST Dairy 258,675 0.7%
Su b t o t al 2 ,8 1 3 ,5 0 2 7 .8 %
No. of farms
*DBS estimates
20,000
18,000 Source: Company data, news sources, DBS Vickers
16,000
14,000
12,000 Market consolidation continues. Top 5 (excluding Bright
10,000
8,000 Dairy) listcos’ production volume grew at a CAGR of 27% in
6,000 2013-2016, suggesting fast market consolidation. With
4,000 lower raw milk prices, production volume grew 19% y-o-y
2,000
0 in 2016 (2015: 17% y-o-y). In 2017F, we expect sales
volume to remain fairly stable and grow at high single digit
2013
2014
2015
2016
2017F
2018F
2019F
*DBS estimates
Source: Company data, company websites, news sources, DBS Vickers
Raw milk price remains under pressure due to imports. In Scale matters
the overseas market, Fonterra whole-milk powder prices
i) Cost efficiency. Production cost per kg has been reducing
(WMP) surged from a low of US$2,070/ton in Aug’16 to
on improving scale and lower raw material costs. However,
US$3,110/ton in July’17 (+45% y-o-y), still far from
the decline is not enough to offset raw milk price volatility.
historical peak of c.US$5,000/ton in 4Q13 . Yet, despite the
In 2016, for instance, production cost per kg ranged
surge in overseas prices, there was no rally for Chinese
between c.Rmb2.5-2.8/kg, which translates into Rmb0.97-
domestic prices, as overseas milk powder still trades at a
1.75/kg of gross profit.
discount to domestic prices. Since January 2017, we
estimate the discount of imported milk powder price to
domestic price has narrowed from 32% to 17%. Cost per kg (before biological fair value adjustment of
dairy farming business)
The attractiveness of import pricing continues to place
pressure on all the large-scale players in 2017. In 1H17, raw
Rmb/kg
milk price has dropped 11% y-o-y to Rmb3.67/kg. This trend 3.5
is expected to continue into 2H17 due to rising milk import. 2.9 2.8
3.0 2.7 2.8 2.7 2.7
That being said, imported milk powder volume growth began 2.5
to slow to 5% y-o-y in 5M17 (vs. 1H15/16 at 16% y-o-y). 2.5
2.0
Raw milk price vs. Fonterra WMP prices (converted to
1.5
raw milk pricing)
1.0
RMB/kg
5.0 0.5
4.5 0.0
4.0 China Modern Shengmu YST Dairy Zhong di
3.5 Dairy
3.0 2014 2015 2016
2.5
2.0 Source: Company data, DBS Vickers
1.5
1.0 Feed costs, comprised of corn, soybean, alfalfa and wheat,
Jan/09
Jan/10
Jan/11
Jan/12
Jan/13
Jan/14
Jan/15
Jan/16
Jan/17
Jul/09
Jul/10
Jul/11
Jul/12
Jul/13
Jul/14
Jul/15
Jul/16
Jul/17
have been reducing over the years. CMD and YST Dairy’s
feed cost/ton declined at a FY14-16 CAGR of 4.4% and
2.7%, respectively. Corn and soybean reported mixed price
China Raw milk International raw milk (est.) changes of -16% and +10% YTD y-o-y. Hence, we expect
overall cost per kg improvement to be limited in FY17F.
Source: Bloomberg Finance L.P., Holstein Farmer, DBS Vickers
3
1
2
1
0
0 China Modern Dairy YST
China Modern Dairy Shengmu YST 2013 2014 2015 2016
2013 2014 2015 2016
Source: Company data, DBS Vickers
Source: Company data, DBS Vickers
ii) Yield per annum. CMD, YST Dairy and Zhongdi Dairy had
Negative cash flow generation. While major dairy farmers
largely reported improvement in yield/annum, achieving a
(excluding biological assets) are still generating profits, their
2014-16 CAGR of 1.8%, 2.1% and -0.3% respectively to
free cash flow has remained in negative territory. Hence, all
yield 9.40-10.7 tonnes/annum in 2016. This, compared with
four companies of CMD, Shengmu, YST Dairy and Zhongdi
the industry average of 6 tonnes/annum, reflects higher
Dairy reported deteriorating financial position over 2014-
efficiency at large-scale farms.
2016, with increasingly higher net gearing ranging from
30%-80% in 2016 (vs. 2015: 20-67%), except for YST Dairy
Yield per annum which sustained a net cash position.
ton/annum
Negative free cash flow *
12
10.7
10.0 9.8
9.4 RMBm
10
8.4 9.0 9.4
0
8 (200)
6 (400)
(600)
4 (800)
(1,000)
2
(1,200)
0 (1,400)
China Modern Dairy YST Zhongdi Dairy
(1,600)
2013 2014 2015 2016 (1,800)
CMD Shengmu YST Dairy Zhongdi
Source: Company data, DBS Vickers
2014 2015 2016
Sector potential vs. major markets. China’s average milk Source: Company data, news sources, DBS Vickers
yield of 6 tonnes/annum still lags that of developed
countries such as the US and the UK. Based on 2016 data, *Includes addition of biological assets & purchase of heifer and calves
average milk yield in the PRC represented a 42% discount
to that in US, and 21% discount to the UK’s, suggesting
room for improvement. Deteriorating financial liquidity – Net cash (debt)
position
Yield per annum – global
RMB m
2,000
12
1,000
10.3
0
10
(1,000)
8 7.6 (2,000)
6.0 (3,000)
6
(4,000)
(5,000)
4
(6,000)
CMD Shengmu YST Dairy Zhongdi
2
2014 2015 2016
0
China USA UK
Source: Company data, news sources, DBS Vickers
Source: Company data, DBS Vickers Look for more partners. Based on our conversation with
major dairy farm operators, most of them have already been
Government subsidies. Dairy farmers could receive small supplying to the top downstream players (Mengniu, Yili and
sums of subsidies for building additional farms (e.g. Bright). Seeking more new partners could also be a good
environmental compliance, equipment purchases, etc.), in opportunity. For example, foreign players who seek to enter
addition to agricultural tax at 0%. China could consider collaboration with local milk producers
to develop fresh products.
Exploring downstream with suitable partners. Dairy farmers,
such as CMD and Shengmu, had been selling fresh milk
under their private labels to try and absorb any surplus of
their raw milk supply. However, due to the fairly high entry
barrier (e.g. high advertising & promotional spending, lack
of bargaining power with distributors), upstream farmers
found it difficult to manage excess inventory by simply
going downstream on their own.
Starting in May’17, CMD has allowed Mengniu to operate
its downstream business. In return, CMD will receive a 3%
gross profit margin. While this could cap the returns from its
downstream business, we believe such an agreement could
at least guarantee a stable payout for CMD although
essentially keeping it as an OEM play.
1,000
%
30
Source: Bloomberg Finance L.P, DBS Vickers
25
20
15
10
0
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
Arla’s milestones
II) Downstream processors fresh consumption trend will see sound growth from a low-
base. Hence, players that place stronger focus in these fast-
Chinese processors have experienced the fastest market growing product categories could see a more sustainable
consolidation, with the top 3 players (Yili, Mengniu, Bright business performance.
Dairy) accounting for >60% of market share by 2016.
Industry growth – by product category (2016)
Market share – Liquid milk
50%
43.9%
100%
90% 40%
30% 0%
20% -2.3%
27.3% 27.4% -10%
10% Liquid milk UHT Premium Chilled Basic UHT
yogurt UHT Yogurt
0%
2015 2016
Source: AC Nielsen, DBS Vickers
Mengniu Yili Bright Dairy Others
Premium pricing is a plus. Based on our sampling, we found
Source: AC Nielsen, DBS Vickers that premium UHT brands were priced at c.14% premium
to fresh milk on a per litre basis. On the other hand, UHT
Categories seeing rising demand. In 2016, UHT yogurt grew yogurt was priced at a c.87% premium against domestic
43.9% y-o-y, outperforming premium UHT milk (+12.6% y- UHT milk. This helps to explain why processors have been
o-y), and chilled yogurt (+11.2% y-o-y). On the flip side, targeting at yogurt categories.
basic UHT milk saw a mild decline of 2.3% y-o-y as the
product becomes too commoditized. We believe UHT
yogurt and chilled yogurt will remain the key drivers, while
basic UHT milk will remain under pressure from growing
imports. In addition, we expect plant-based alternatives and
Bright Dairy Momchiltov si (2 F ruit 3 V egetable) UHT y ogurt China J D.com 23.0
Plant-based alternatives market share (%) Imported milk powder ASP vs. Fonterra whole-milk
powder prices
% US$/ton
30 7,000
25 6,000
20 5,000
15 4,000
3,000
10
2,000
5
1,000
0
Jan-10
Jan-11
Jan-12
Jan-13
Jan-14
Jan-15
Jan-16
Jan-17
Jul-10
Jul-11
Jul-12
Jul-13
Jul-14
Jul-15
Jul-16
2011
2012
2013
2014
2015
2016
Imported milk powder
Coconut Palm Yinlu
Whole milk powder (Fonterra)
Lolo Vitasoy
Skim milk powder (Fonterra)
Daliyuan
Source: Euromonitor, DBS Vickers Source: China Customs, Bloomberg Finance LP, DBS Vickers
Downstream could be more sustainable. Downstream prices. Separately, while China’s dairy demand is expected
processors have been remarkably more profitable due to to grow steadily, we believe major downstream operators
several reasons. First, with strong bargaining power, with strong balance sheet could be in a better position to
processors are able to put price pressure on upstream look beyond China via M&As to further strengthen their
players. Second, due to the large price disparity between domestic portfolio as well as exploring into overseas growth
domestic and overseas sourcing, processors have opportunities.
increasingly opted to use imported sources that offer better
Dairy M&As
M ark et
Dat e Company T arget St ak e Loc at ion M et ric V aluat ion Complet e?
v alue
J ul-10 Bright Dairy Sy nlait Dairy (Private) 51.0% Overseas NZD m 58 Y
Dec-10 Mengniu J unlebao (Private) 51.0% Domestic RMB m 470 Y
China Modern Dairy 16.9x FY13 P/E or 1.6x
May-13 Mengniu 26.9% Domestic HK$m 3,175 Y
(1117.HK) P/B
23.7x FY13 PE or 3.35x
J un-13 Mengniu Yashili (1230.HK) 76.6% Domestic HK$m 9,540 Y
PB
Nov -13 Mengniu YST Dairy (1431.HK) ~4% Domestic HK$m 470 25.6x FY13 PE Y
Mengniu &
J an-14 Whitewav e Yashili Zhengzhou Plant 100.0% Domestic RMB m 377 Y
(51/49)
39.5x FY13 PE, or 5.0x
F eb-14 Danone, COFCO Mengniu (2319.HK) 6.2% Domestic HK$m 5,153 Y
P/B
Mar-14 F osun International Sanyuan Food (600429:CH) 20.5% Domestic RMB m 2,000 187.7x FY14 PE, or 3.7x
May-14 Bright Food Tnuv a (Private) 56.1% Overseas US$m 2,500 43.2x FY14 PE Y
J ul-14 Mengniu Shengmu Dairy (1432.HK) ~4% Domestic HK$m 112 17x FY14 PE or 2.9x PB Y
Oct-14 Danone Yashili (1230.HK) 25.0% Domestic HK$m 4,390 44x FY14 PE Y
F eb-15 Bright Food Tnuv a (Private) 20.7% Overseas US$m 1,290 60.5x FY14 PE Y
Mar-15 F onterra Beingmate (002570:CH) 18.8% Domestic RMB m 775 80.3x FY14 PE Y
New J ufeng Packaging新巨
J un-15 Yili 20.0% Domestic RMB m 96 Y
丰 (Priv ate)
Xinjiang Western Yili Shihei Company (Milk
Aug-15 100.0% Domestic RMB m 90 Y
Animal powder, Liquid milk)
Oct-15 Yashili Mengniu Arla (51/49) 100.0% Domestic RMB m 1,050 13.3x FY14 PE
J an-16 Ornua Ambrosia Dairy (Priv ate) 100.0% Domestic Y
Herman Shao-ming
Mar-16 V an Diemen's Land (Private) 100.0% Overseas AUS m 220 Y
Hu, Kenny Zhang
23.4x EV /LTM Adjusted
Sep-16 Danone Whitewave Foods 100.0% Overseas US$m 12,500 Y
EBITDA (2016)
17.5x FY16 PE or 1.9x
Oct-16 Yili Shengmu Dairy (1432.HK) 37.0% Domestic HK$m 5,290 N
P/NAV
China Modern Dairy
J an-17 Mengniu 33.3% Domestic HK$m 4,671 Y
(1117.HK)
May-17 Yili Stonyfield (Danone) 100.0% Overseas US$m 850 N
J un-17 Sy nlait Dairy New Zealand Dairy Company 100.0% Domestic NZD m 57 Y
Shanghai Holstein (RRJ
J ul-17 Bright Dairy 45.0% Domestic US$m 315 Pending
Capital)
J ul-17 Lactalis Stonyfield (Danone) 100.0% Overseas US$m 875 Y
1. Yashili - A cquisition of
1. A grees to jointly dev elop
M engniu's Oumei, Danone's
Increasing brand w ith Sterilgarda A limenti 1. Bright F ood (Parent) acquired
Dumex, and A rla's M erla
competitiv eness: S.p.A under Perfectland T nuv a (Israel), the largest dairy
2. Danone and A rla as
Ov erseas collaboration 2. Place bid on Danone's cooperativ e in Israel w ith strong
shareholders - A 20 (Danone)/80
& M &A s Stony field (US-based y ogurt) for expertise in cheese and butter.
v enture to dev elop Bio (A ctiv ia) -
US$850m, but failed
Danone's largest y ogurt brand.
Net gearing (x) 18.8% (F Y17F ) Net cash (F Y16) 15% (F Y17F )
Net profit 2 3 1
T o t al 2 3 1
China M odern
F Y 16 Shengmu Dairy Y ST Dairy Z hongdi
Dairy
1117.HK 1432.HK 1431.HK 1492.HK
Produc t iv it y met ric M et ric
Herd size k heads 230 123 54.7 55.3
Herd size growth % y -o-y 1.6% y -o-y 10.7% y -o-y 9.9% y -o-y 23.7% y -o-y
Sales v olume m tonnes 1m 0.6m 0.3m 0.2m
Sales v olume growth % y -o-y 9% y -o-y 16% y -o-y 11% y -o-y 123% y -o-y
ASP Rmb/kg 4.08(conso.) 4.45 3.98 3.82
F eed cost Rmb/kg 2.48 n.m 1.98 1.88
Total cost Rmb/kg 2.74 2.21 2.67 2.44
Milk y ield Tonne/annum 9.4 n.m 10 10.7
F inanc ial met ric
Sales % y -o-y % 1% 12% 0% 99%
2016 Rmb m 4,862 3,467 1,029 962
2015 Rmb m 4,826 3,101 1,033 483
Upstream sales % 2% -6% 0% 100%
2016 Rmb m 3,384 1,360 1,029 856
2015 Rmb m 3,324 1,445 1,033 428
Gross margin (conso.) % 33.0% 48.3% 33.0% 33.7%
Gross margin (upstream)
2016 % 30.7% 47.4% 33.0% 36.2%
2015 % 31.7% 46.1% 36.8% 42.6%
SG&A expenses % of sales% 22% 12% 9% 11%
Net debt (cash) Rmb m 5,955 1,503 Net cash Net cash
Current ratio x 0.5 1.6 1.9 0.5
ROE (%) % -10.0% 13.8% -2.0% 5.7%
ROA (%) % -4.2% 6.8% -1.8% 3.1%
France
Infant formula – Distribution of baby food by format (% 7%
value) – 2011-2016
% NZ
80
Others 11%
70
23%
60
50 Source: China Customs, DBS Vickers
40
30 Other channels. Despite prior regulations required by the
20 Certificate & Accreditation Administration (CNCA) for offline
10 channels, brands are able to bypass this through basic
0 registration via bonded warehouses in China, or even by
2011
2012
2013
2014
2015
2016
Baby, Infant and Toddler Milk Formula Registration. In months. This, coupled with more marketing & promotion,
Oct’16, a new set of guidelines was issued for domestic and should drive a recovery in the top-line.
foreign infant formula manufacturers. Infant formula brands
Actions taken by brands. There are currently 68 overseas
exported to China must register with CFDA by 1-Jan-2018,
plants registered with CNCA (see Appendix: page 74). Due
before marketing in China. Infant formula registration will
to the time consuming nature of the registration process,
involve product testing, technical evaluation, on-site
selected infant formula brands have taken the initiative to
inspection of manufacturing plants, sample inspection,
purchase equity stakes in manufacturing bases already
development capacity, and the approval & issuance of
registered with CNCA. That being said, CNCA license is not
certificates. In principle, each company may only apply for at
a guaranteed safe pass, as Camperdown International had
most 9 formula products with 3 series. This includes stage 1
its license suspended recently.
(0-6 months), stage 2 (6-12 months) and young children
formula (12-36 months) in each plant. Based on our latest
understanding, some firms have started to submit their Taking a stake in registered infant formula
manufacturing plants
applications in early Jan-Feb, and are expected to receive a
response by Aug 2017 at the earliest. D at e Co mp an y T arg et Paid St ak e
Reducing inventory. Given the current regulatory changes, Bright Dairy
distributors have been cautious in holding onto inventories Sep-10 (Pure Sy nlait Dairy NZ$82m 51%
before the visibility of registration approvals become clearer. Canterbury )
0 A ustralian
May -17 A usnutria Rmb170m 100%
Milk Pow der
(20)
New Zealand
(40) J un-17 Sy nlait Dairy Dairy NZ$56.5m 100%
2010 2011 2012 2013 2014 2015 2016 Company
Camperdow n
Yashili Biostime Beingmate J un-17 Bellamy 's A US$28.5m 90%
Int'l
Mason
Source: Company data, DBS Vickers F inancials
J ul-17 Blend & Pack A US$80m 80%
(A iy ingdao-
What to expect next? Local manufacturers are reducing retailer)
production capacity in China, and shifting to overseas plants Watton
as Chinese consumers still prefer infant formula products J ul-17 Health Blend & Pack A US$5m 5.0%
A ustralia
that are 100% made in developed markets abroad, such as
Europe, New Zealand, etc. For example, H&H’s Changsha Source: Company data, DBS Vickers
infant formula plant, or Yashili’s manufacturing plants will
start to produce other nutritional products and adult milk
powder instead. Looking ahead, infant formula players will
likely begin to restore inventory levels once better
transparency of registration approvals is seen in the coming
Regulations Description
CNCA require infant formula produced overseas to comply with Chinese labelling requirements, such as
CNCA
translated label, nutrient information etc. New advertising laws must be complied.
China label product must comply with the new Advertising Law. This bans formula makers from making
claims to replace mother's milk, in addition to misleading content such as express and imply the function
New China Advertising Law
of disease prevention or treatment, health function, improving intelligence, "zero-added", "no
added,""do not contain “ in products, exaggerated wording etc.
China Cross Border E-commerce
New taxation on both E-commerce Bonded mode and Cross Border mode (1) imports
tax change
Administrative Rule for Recipe
CFDA Formula registration; domestic / imported product to be compliant with WTO submission on 3
Registration of Baby Formula
product lines (9 formulas). All recipes must be registered under CFDA.
Powder (CFDA)
Shaanxi
Zhejiang
Guangdong
Shanxi
Qinghai
Gansu
Jiangsu
Guangxi
Hebei
Yunnan
Jiangxi
Sichuan
Tianjin
Henan
Hainan
Hubei
Beijing
Hunan
Liaoning
Guizhou
Inner Mongolia
Fujian
Anhui
Jilin
Xinjiang
Ningxia
Chongqing
Heilongjiang
Shandong
cu. meters
0.40
0.35
0.30
0.25
0.20
0.36
0.15
0.10
0.05 0.10 0.08 0.06 0.05 0.04
0.00
United India Brazil China Indonesia Mexico
States
Cold Storage Per Capita
R an k /
Co mp an y O w n er ( s ) Co re B u s in es s
( n et c h an g e)
1 Rokin Logistics CJ Korea Express Refridgerated ground transport
2 (+1) Xiany i Supply Chain Xiany i Holdings Integrated cold chain logistics solution
3 (+3) SF Express M ingde Holding (Wang Wei) Express mail and parcel
4 (-2) Shuanghui Logistics Shuanghui Group Refridgerated ground transport
Refridgerated ground transport &
5 (-1) Speed F resh Logistics Bright Dairy & F ood
w arehouse
Shanghai Exfresh Logistics Refridgerated ground transport &
6 (New ) Yiguo Group
Technology w arehouse
7 (+4) HNA Cold Chain Logistics HNA Group Integrated cold chain logistics solution
8 (-1) Hav i N/A Specialty food cola-chain logistics
9 DCH Logistics N/A Specialty food cola-chain logistics
Refridgerated ground transport &
10 China M erchants A mericold China M erchant Port, A mericold
w arehouse
STOCK PROFILES
Correlation with dairy prices Share price vs. whole milk powder prices (Fonterra)
Mengniu’s share price is largely uncorrelated with China raw
milk prices. We believe the proportion of domestic raw milk US$/ton HK$
used as raw material has declined in the past few years, and 6,000 4.50
replaced by imported milk powder. 4.00
5,000
3.50
4,000 3.00
Share price vs. China raw milk prices 2.50
3,000
2.00
RMB/kg HK$ 2,000 1.50
4.5 25 1.00
1,000
0.50
4.0 20 0 0.00
May/13
Oct/13
Feb/12
Mar/14
Apr/11
Sep/11
Apr/16
Sep/16
Jan/15
Aug/14
Dec/12
Jun/15
Nov/10
Jul/12
Nov/15
3.5
15
3.0
10
2.5 WMP China Modern Dairy (RHS)
2.0 5
Source: Company data, Bloomberg, DBS Vickers
1.5 0
May/13
Feb/12
Oct/13
Mar/14
Apr/11
Sep/11
Apr/16
Sep/16
Jan/10
Jan/15
Aug/14
Dec/12
Jun/10
Jun/15
Nov/10
Jul/12
Nov/15
Jan/11
Jan/12
Jan/13
Jan/14
Jan/15
Jan/16
Jan/17
Jul/10
Jul/11
Jul/12
Jul/13
Jul/14
Jul/15
Jul/16
its share price, as Fonterra dairy prices serve as a good
indicator to China demand (>70% of China exports come
from New Zealand), and it has a direct impact on Mengniu’s Imported milk powder (LHS)
gross margin. China Mengniu (RHS)
Sales
CRITICAL FACTORS TO WATCH
Ice cream
Yogurt 4%
Critical Factors 28%
Milk Other dairy
Sales growth is a critical driver for China Mengniu, as it offers
beverages products
insight on the market demand growth, in addition to 17% 1%
performances of core and new product offering.
Infant
formula
Milk Deluxe’s performance. Mengniu’s largest sales contributor is UHT milk 6%
liquid milk segment (89.4% of FY16 sales), which comprises of 44%
UHT milk, milk beverages, and yogurt. UHT milk accounts for
44% of liquid milk sales, and sales at this division is largely driven
by Milk Deluxe (特侖蘇), a premium UHT milk. Within the UHT Yogurt sales
milk range, Mengniu also offers milk targeted at children - Future RMB m
Star (未来星) series, Arla UHT milk - and Awakening Youth Milk 25,000 60%
(煥輕)targeting the elderly. Mengniu’s UHT product market 20,000 50%
share grew marginally by 0.6ppts to 27.9% in FY16. We expect 40%
15,000
UHT milk sales to expand by 6% CAGR in FY16-18F. 30%
10,000
20%
5,000 10%
Yogurt product offerings. The strongest driver in recent years
0 0%
under liquid milk has been yogurt, comprising of Just Yogurt (純 2014 2015 2016 2017F 2018F
甄), Champion (冠益乳) and Bio+. We expect yogurt sales to Sales Growth (%)
deliver CAGR of 17% in FY16-18F, driven by new SKUs and
product mix enhancement. Mengniu has launched new SKUs
Gross margin (%)
under Champion and Milk Deluxe (premium series). In FY16, 34.0%
Mengniu’s chilled yogurt market share saw a mild contraction of 34% 34%
33.5% 33%
0.6ppt to 31.4%.
33.0% 33%
22.0
20.0 B
C D
18.0 G
F
16.0 H
A
14.0 E
12.0
10.0
Jan-14
Jan-15
Jan-16
Jan-17
Jul-13
Jul-14
Jul-15
Jul-16
Oct-13
Oct-14
Oct-15
Oct-16
Apr-13
Apr-14
Apr-15
Apr-16
Apr-17
We chronicled our views on the drivers and events that have shaped China Mengniu’s share price, as follows:
(A) Subsequent to Danone becoming a strategic shareholder of Mengniu in May’13, Mengniu share price rallied with the increase
in stake in Yashili (1230.HK)
(B) Mengniu introduces a change in shareholding structure, with strategic alliances with Danone and Arla.
(C) Mengniu sold 25% of its Yashili stake to Danone and other shareholders to comply with free-float requirement to maintain its
listing status
(D) Imported milk powder volume dropped 41% y-o-y – investors cautious on a supply glut
(F) Mengniu saw a surprising overhaul of the management of Sun-Yi-ping, replaced by Yashili’s CEO Jeffrey Lu.
(G) Profit warning announced, primarily due to an one-off provision write-off on Yashili, weaker profits from China Modern Dairy,
and booking bulk powder losses
Balance Sheet:
Strong refinancing ability. In Mar’17, Mengniu completed a Leverage & Asset Turnover (x)
partial cash offer for CMD for HK$2,798m (c.23.5% of CMD’s
share capital), and raised its shareholding from 25.4% to
61.3%. As part of its refinancing, Mengniu also entered into a
subscription agreement for zero-coupon exchangeable bonds of
US$194.8m, with a maturity date in Jun’22, and exchangeable
into 684.4m CMD shares (11.24% of share capital) at
HK$2.1995/sh.
Key Risks:
Food safety issues
Mengniu may be affected by dairy-related industry news
concerning food safety issues.
Jan-14
Jan-15
Jan-16
Jan-17
Growth
Revenue Gth (%) 6.7 (1.1) (3.1) 6.6 13.0
Opg Profit Gth (%) 49.1 20.6 (18.5) 3.7 (265.4)
Net Profit Gth (%) 47.7 27.7 (21.0) (19.5) N/A
Margins
Gross Margins (%) 29.1 31.9 30.8 33.7 31.9
Opg Profit Margins (%) 6.0 5.8 5.0 5.6 (7.3)
Net Profit Margins (%) 5.4 5.2 4.4 4.0 (6.9)
Source: Company, DBS Vickers
Jan-17
Dec-16
May-17
Jun-17
Nov-16
Jul-16
Jul-17
Oct-16
Feb-17
Apr-17
Aug-16
30
25 E
B
D
C
20 F
A
G H I
15
10
5
Sep‐13
Sep‐14
Sep‐15
Sep‐16
Jul‐17
Jul‐13
Jul‐14
Jul‐15
Jul‐16
Mar‐16
Mar‐17
Mar‐13
Mar‐14
Mar‐15
Nov‐15
Jan‐16
Nov‐16
Jan‐17
Jan‐13
Nov‐13
Jan‐14
Nov‐14
Jan‐15
May‐16
May‐17
May‐13
May‐14
May‐15
px last
A) Jul’13 - Synlait Dairy successfully lists on New Zealand stock exchange at NZ$2.2/sh (or 21.5x/16.4x FY13/14 PE) – Bright’s
shareholding reduced to 39.1% (Prior: 51%) on new share offering.
C) May’14 – Bright Food finalises 56% stake acquisition of Tnuva for NIS4.8bn (NIS8.6bn) from Apax Partners. Based on 2014
figures, Bright valued Tnuva at 23x forward PE. Tnuva is a dairy cooperative with over 70% market share in Israel,
and engages in the sales and production of meats, eggs and other packaged food.
D) Mar’15 – Chinese authority approves Bright Food’s acquisition of Tnuva, and Bright was negotiating to increase its stake up
to c.76.8%. Bright subsequently suspends its shares until July 23rd 2015.
E) Jun’15 – Bright approves of the acquisition of Tnuva from Parent Company, Bright Food. Tnuva was valued at EUR1bn. On
the same day, Bright announces the potential new-share placement of not more than 559m shares at Rmb16.1/sh,
raising not more than Rmb9bn of gross proceeds. to six parties including 信晟投资 (39% of placement shares), 晟创
投资 (c.33.2%) ,益民集团 (11%) ,上汽投资 (5.6%),国盛投资 (5.6%) ,浦科源富达壹(5.6%). This implied 45.7x FY15
PE.
F) Jul’15. – Bright applies for a temporary trading halt as a result of acquisition of Bright Food’s assets and the pending new
share placement.
– Bright’s upstream venture with RRJ Capital agrees to acquire upstream assets from its Parent Company.
H) Mar’17 – Bright releases FY16 results – Sales increased 7.1% y-o-y, while earnings declined 5.5%. Of which, liquid milk
reported flat sales versus Mengniu (+11%) or Yili (+5%), which suggests potential market share losses in key
categories.
I) Jul’17 – Bright repurchases 45% stake from RRJ Capital of Shanghai Holstein for US$315m.
Balance Sheet:
With the repurchase of Chatsworth (upstream assets) for Leverage & Asset Turnover (x)
US$315m, we expect Bright Dairy will turn net gearing of 14% 1.4
0.50 1.4
(FY16: net cash). We expect capex to remain unchanged at 1.4
Rmb900m-1bn in FY17F from new plants and production lines 0.40
1.3
Capital Expenditure
Favourable government policy. Government-led market RMBm
consolidation will be favourable to the largest dairy players in 2,500.0
1,500.0
Key Risks:
Raw milk cost, feed cost, imported milk powder cost has an 1,000.0
0.0
Food safety issue 2015A 2016A 2017F 2018F 2019F
and cheese). The company has six sales centres nationwide 2.0%
(East, North, Central South, UHT products, whey protein
0.0%
materials, and dairy cows), and operations platform (milk 2015A 2016A 2017F 2018F 2019F
powder, logistics, and overseas). Bright holds a 39% stake in Forward PE Band
New Zealand-based Synlait Dairy, its first offshore milk (x)
processing facility. 76.5
66.5
56.5
+2sd: 58.5x
46.5
+1sd: 48.4x
36.5
Avg: 38.4x
26.5
‐1sd: 28.4x
16.5 ‐2sd: 18.4x
Jul-13 Jul-14 Jul-15 Jul-16 Jul-17
PB Band
(x)
7.9
6.9
+2sd: 6.58x
5.9
+1sd: 5.48x
4.9
Avg: 4.37x
3.9
‐1sd: 3.27x
2.9
‐2sd: 2.16x
1.9
Jul-13 Jul-14 Jul-15 Jul-16 Jul-17
Growth
Revenue Gth (%) 21.8 1.9 (13.6) 2.1 6.7
Opg Profit Gth (%) 6.3 (3.7) 9.5 81.0 42.8
Net Profit Gth (%) 39.9 (4.0) (39.8) 19.7 48.4
Margins
Gross Margins (%) 44.9 39.7 30.9 35.8 25.9
Opg Profit Margins (%) 4.4 2.9 5.6 5.1 7.4
Net Profit Margins (%) 3.3 2.0 2.3 2.3 3.2
Source: Company, DBS Vickers
S.No . Da te Cl o s i n g 1 2 -mth R a ti n g
RMB
Pri c e Ta rg e t
17.0
Pri c e
15.0 1 1: 21-Nov-16 RMB13.95 RMB14.50 Hold
13.0
11.0
9.0
7.0
5.0
3.0
Jul-16
Dec-16
Jul-17
Oct-16
Feb-17
May-17
2.9 138 partly due to higher feed costs forecast. Excluding one-offs
(cancellation of share options, biological changes and doubtful
118
2.4
98
1.9
1.4
78
58
debts), we expect earnings of CMD to recover in FY18F on the
0.9
Jul-13 Jul-14 Jul-15 Jul-16
38
Jul-17
back of lower selling expenses mainly.
China Modern Dairy (LHS) Relative HSI (RHS)
Potential catalysts. A recovery in raw milk prices could support
Forecasts and Valuation
an upstream recovery. This is dependent on consumer
FY Dec (RMB m) 2016A 2017F 2018F 2019F
Turnover 4,862 4,901 5,352 5,827 demand, and international pricings. In our view, it is difficult
EBITDA 946 822 989 1,104 for upstream players to see this recovery, given the excess
Pre-tax Profit (785) (645) 86 137 supply situation from imports. In addition, deteriorating cash
Net Profit (742) (646) 84 135
Net Pft (Pre Ex) (core profit) 317 154 284 385 flow may place greater need on more debt or equity fund
EPS (RMB) (0.14) (0.11) 0.01 0.02 raising in the future.
EPS (HK$) (0.16) (0.12) 0.02 0.03
Core EPS (HK$) 0.07 0.03 0.05 0.07
Valuation:
Core EPS (RMB) 0.06 0.03 0.05 0.06
Core EPS Gth (%) (63.0) (57.1) 84.9 35.3 Our TP of HK$1.52 is based on DCF valuation. Key
Diluted EPS (HK$) (0.16) (0.12) 0.02 0.03 assumptions include WACC at 9.1%, and terminal growth of
DPS (HK$) 0.00 0.00 0.00 0.00 3%.
BV Per Share (HK$) 1.50 1.20 1.21 1.24
PE (X) nm nm 93.0 58.2
Core PE (X) 21.9 50.9 27.6 20.4 Key Risks to Our View:
P/Cash Flow (X) 6.1 8.1 7.4 6.7 An increase in stake by Mengniu, or government intervention.
P/Free CF (X) nm nm 29.9 24.0
EV/EBITDA (X) 13.3 17.9 14.9 13.4 At A Glance
Net Div Yield (%) 0.0 0.0 0.0 0.0
Issued Capital (m shrs) 6,131
P/Book Value (X) 1.0 1.2 1.2 1.2
Net Debt/Equity (X) 0.8 1.0 1.0 1.0 Mkt. Cap (HK$m/US$m) 9,059 / 1,160
ROAE (%) (10.0) (9.7) 1.3 2.1 Major Shareholders
Earnings Rev (%): nm nm New China Mengniu Dairy Company Limited (%) 61.3
Consensus EPS (RMB) 0.98 1.11 1.27 Free Float (%) 27.5
Other Broker Recs: B: 20 S: 0 H: 2 3m Avg. Daily Val. (US$m) 0.5
Source of all data on this page: Company, DBSV, Thomson Reuters, ICB Industry : Consumer Goods / Beverages
HKEX
2.0
Critical Factors
1.0
Raw milk prices. As the leading dairy farm in China, CMD is
subjected to domestic raw milk price volatility, sales volume 0.0
2014 2015 2016 2017F 2018F
and feed costs. Due to trade influx, raw milk price is driven by
Milk yield (tonne/annum)
supply. As such, the company is planning to absorb the
RMB/tonne
upstream supply through expansion into downstream business. 9.80
However, this did not work out well due to high cost of entry 9.59
9.60 9.49
into the modern trade channel. We expect avg. raw milk prices 9.40
9.40
to decline by 7% y-o-y to Rmb3.67/kg, thereafter a mild 9.10
9.20
growth of 2% in 2018F. 8.90
9.00
8.80
International dairy prices. CMD’s share price is positively
8.60
correlated to international dairy price changes, as the price acts
8.40
as a function of demand of China. However, we believe this 2014 2015 2016 2017F 2018F
relationship will diverge given the general lack of correlation Milk yield (tonne/annum)
between domestic raw milk prices and international prices.
9.88 9.4 9.5 9.6 9.7
9.1
779
519
260
0
2015A 2016A 2017F 2018F 2019F
Source: Company, DBS Vickers
China raw milk prices vs. CMD share price International dairy price vs. share price
May/13
Feb/12
Oct/13
Mar/14
Apr/11
Sep/11
Apr/16
Sep/16
Jan/15
Aug/14
Dec/12
Jun/15
Nov/10
Nov/15
Jul/12
May/13
Feb/12
Oct/13
Mar/14
Apr/11
Sep/11
Apr/16
Sep/16
Jan/15
Aug/14
Dec/12
Jun/15
Nov/10
Jul/12
Nov/15
China Raw Milk (LHS) China Modern Dairy (RHS) WMP China Modern Dairy (RHS)
We chronicled our views on the drivers and events that have shaped China Modern Dairy’s share price, as follows:
May’13 – China Mengniu agrees to buy 984m shares from KKR (20.4%) and 312m shares from CDH (6.5%) at HK$2.45/sh. This
amounted to HK$3.2bn.
Sept’13 – KKR, CDH to lead a joint-venture to build two 10,000-head cow farms over a 2-year period with CMD. The joint venture
will be 82% owned by KKR and CDH, and 18% owned by CMD.
Mar’14 – Fonterra milk powder prices began on a decline after a quick surge in 2H13. Subsequently, China raw milk prices
declined in 2014.
Jun’16 - In exchange for acquiring a 45% equity interest in its downstream sales and distribution Company, CMD agrees to issue
338.6m new shares at HK$1.46/sh to the holders.
Jan’17 – KKR, CDH sell their stake to China Mengniu for HK$1.87bn. This is equivalent to 956.5m shares at HK$1.94/sh. At the
same time, Mengniu placed a partial offer to the open market at the same price. As a result, Mengniu’s effective stake rose to
61.4%.
Balance Sheet:
Lower capital expenditure. FY17 capex is budgeted at around Leverage & Asset Turnover (x)
Rmb800m. We expect weaker raw milk price to likely have a 1.20
0.4
0.4
negative impact on cash flow. Hence, we expect net gearing to 1.00 0.4
rise in FY17F (FY16: 80%). 0.3
0.80
0.3
0.60 0.3
Share Price Drivers: 0.3
Rebound in raw milk prices. A rebound in raw milk prices will 0.40 0.3
Capital Expenditure
Stronger growth in downstream operations. CMD is RMBm
expanding its product range progressively to lower its reliance 2,500.0
Sector and capital risks. Key earnings risks include animal 500.0
disease which could hurt milk production, fluctuation of raw
0.0
material prices, reduction of intake by Mengniu which is one 2015A 2016A 2017F 2018F 2019F
of its key customers, as well as food safety issues. Capital Expenditure (-)
ROE
4.5%
Company Background
4.0%
Largest upstream dairy player. Established in 2005 in 3.5%
Maanshan, Anhui, China Modern Dairy (CMD) is the largest 3.0%
upstream dairy company in terms of herd size as well as the 2.5%
0.5%
0.0%
A pioneer in large-scale dairy farming. CMD is among the first 2015A 2016A 2017F 2018F 2019F
25.8 Avg: 25.6x
Expand operations downstream. CMD has expanded its 15.8
‐1sd: 10.4x
operations downstream under the brand Modern Farming. 5.8
-4.2
Jul-13 Jul-14 Jul-15 Jul-16 Jul-17
PB Band
(x)
2.8
+2sd: 2.51x
2.3
+1sd: 1.99x
1.8
Avg: 1.46x
1.3
‐1sd: 0.93x
0.8
0.3
‐2sd: 0.4x
Dec-13 Dec-14 Dec-15 Dec-16
Key Assumptions
FY Dec 2015A 2016A 2017F 2018F 2019F
Raw milk price (CMD) 32.3 30.9 27.4 26.6 25.5
Milk yield (tonne/annum) 9.1 9.4 9.5 9.6 9.7
Sales volume ('000
924.1 1,009.9 1,090.6 1,177.9 1,272.1
tonnes)
Source: Company, DBS Vickers
Growth
Revenue Gth (%) N/A N/A (8.5) 10.2
Opg Profit Gth (%) N/A N/A (158.6) (194.0)
Net Profit Gth (%) N/A N/A N/A (35.8)
Margins
Gross Margins (%) 36.5 32.2 32.5 33.4
Opg Profit Margins (%) 27.6 1.0 (17.7) (0.9)
Net Profit Margins (%) 19.6 (5.4) (25.4) (6.7)
Source: Company, DBS Vickers
S.No . Da te Cl o s i n g 1 2 -mth R a ti n g
HK$
Pri c e Ta rg e t
3.0 3 4 5 Pri c e
2.5 1 2 1: 24-Aug-16 HK$1.21 HK$1.10 Hold
2: 25-Oct-16 HK$1.94 HK$1.70 Hold
2.0 3: 21-Nov-16 HK$1.89 HK$1.70 Hold
4: 29-Mar-17 HK$1.77 HK$1.69 Hold
1.5 5: 27-Apr-17 HK$1.66 HK$1.54 Hold
1.0
0.5
0.0
Jul-16
Jul-17
Aug-16
Jun-17
Oct-16
Nov-16
Feb-17
May-17
Sep-16
Jan-17
Mar-17
Apr-17
Dec-16
Page 60
ed-TH / sa- DL
DBSV's discussion of the issuer in this report will not be continuously followed. Accordingly, this report is being provided as a stand-alone analysis and recipients of this report should not expect
additional reports relating to this issuer, unless so decided by DBSV
China Dairy Sector
Inner Mongolia Yili Industrial-A
FY16 earnings improvement from favourable raw material cost margin contracted 3.6ppt to 37.9% (1Q16: 41.5%) on higher
and product mix. In FY16, Yili's liquid sales (82% of FY16 sales) raw material costs.
grew 5% y-o-y (volume +3%, ASP +2%), while ice-cream sales
grew 2% (ASP +12%, volume -9%). Milk powder sales SG&A as % of sales trend
declined 15% y-o-y mainly on weaker sales volume. In FY16,
new SKU contribution reached 22.7% (+7ppt y-o-y), while star
35%
SKUs' (Satine, Anmuxi, Changqing, Pro-Kido, and Chocolat)
contribution reached 49% of sales (+3.2ppt y-o-y) 30%
25%
Sales growth (%) – by segment
20%
40% 15%
30% 10%
20%
5%
10%
0%
0% 2010 2011 2012 2013 2014 2015 2016
-20%
Source: Company data, DBS Vickers
-30%
Liquid milk Ice-cream Milk powder &
dairy related
Commands strongest GPM among peers. Yili’s gross margin is
2010 2011 2012 2013 2014 2015 2016
the highest among peers at 38.2% in FY16, due to its higher
sales contribution from infant milk formula. Since August 2016,
Source: Company data, DBS VICKERS
imported milk powder’s upswing began to have a negative
impact on Yili’s gross margin.
45%
Ice-cream
7% 40% 38%
Milk
powder & 35%
dairy
related 30%
9%
25%
Liquid milk
20%
82% Others
2% 15%
3Q08: Melaninine scandal
10% impacted dairy sector
5%
1Q08
3Q08
1Q09
3Q09
1Q10
3Q10
1Q11
3Q11
1Q12
3Q12
1Q13
3Q13
1Q14
3Q14
1Q15
3Q15
1Q16
3Q16
1Q17
Source: Company data, DBS VICKERS Source: Company data, DBS VICKERS
Page 61
China Dairy Sector
Inner Mongolia Yili Industrial-A
Cash ready for M&As. Yili’s capital expenditure averaged at
Rmb3.6bn in 2013-16, mainly focused on liquid milk capacity
expansion (5.9% free cash flow yield). This is similar to Hong Kong Northbound Trading (shareholding)
Mengniu’s capex spending of roughly Rmb3bn p.a. Yili is cash
rich against peers, with a net cash position at Rmb13.7bn. As Hong Kong De pository Re se rve
Yili failed to acquire US-based yogurt producer Stonyfield from No. of sha re s %
Danone for US$850m, we expect Yili to be on the prowl for 4Q14 66 2.15%
overseas acquisitions. Compared with its peers, Yili has been 1Q15 197 6.44%
more prudent in M&As. 2Q15 375 6.12%
3Q15 321 5.23%
4Q15 256 4.22%
Cash flow generation
1Q16 284 4.68%
2Q16 377 6.22%
15,000 3Q16 416 6.86%
4Q16 348 5.74%
10,000 1Q17 394 6.48%
2Q17* 519 8.54%
5,000
* Based on Stock Connect Shareholding 19/7/17
0 Source: Company data
(5,000)
(10,000)
(15,000)
2010 2011 2012 2013 2014 2015 2016
Page 62
China Dairy Sector
Inner Mongolia Yili Industrial-A
Income Statement (RMB m) Balance Sheet (RMB m)
F Y Dec 2013A 2014A 2015A 2016A F Y D ec 2013A 2014A 2015A 2016A
Rev enue 47,545 54,251 60,109 60,189 Net F ixed Assets 12,786 14,981 16,269 15,474
Cost of Goods Sold (34,083) (36,400) (38,376) (37,427) Inv ts in Assocs & J V s 34 26 122 1,631
G ro ss Pro f it 13,462 17,851 21,733 22,762 Other LT Assets 3,590 3,487 3,454 1,964
Other Opg (Exp)/Inc (10,968) (13,414) (16,728) (17,617) Cash & ST Inv ts 8,140 12,461 12,217 13,211
O p erat in g Pro f it 2,495 4,437 5,005 5,145 Inv entory 3,683 5,008 4,663 4,326
Other Non Opg (Exp)/Inc 524 449 650 1,484 Debtors 522 652 719 686
Associates & J V Inc 4 (2) 6 (8) Other Current A ssets 4,122 2,880 2,187 1,969
Net Interest (Exp)/Inc 37 (99) (137) 10 T o t al A sset s 32,877 39,494 39,631 39,262
Exceptional Gain/(Loss) - - - -
Pre- t ax Pro f it 3,060 4,786 5,524 6,632 ST Debt 4,251 8,338 6,753 488
Tax 141 (619) (869) (963) Creditors 5,192 5,281 6,079 6,753
Minority Interest (14) (22) (23) (7) Other Current Liab 6,074 5,138 5,370 7,667
Preference Div idend - - - - LT Debt 0 704 0 0
Net Pro f it 3,187 4,144 4,632 5,662 Other LT Liabilities 1,047 1,212 1,283 1,119
Net Profit before Except. 3,187 4,144 4,632 5,662 Shareholder's Equity 16,125 18,634 19,984 23,082
EBITDA 3,617 5,860 6,729 6,698 Minority Interests 188 188 162 154
Rev enue Gth (%) 13.9 14.1 10.8 0.1 T o t al Cap . & L iab . 32,877 39,494 39,631 39,262
EBITDA Gth (%) 42.7 62.0 14.8 (0)
Opg Profit Gth (%) 52.3 77.9 12.8 2.8 Non-Cash Wkg. Cap (2,940) (1,878) (3,879) (7,439)
Effectiv e Tax Rate (%) (4.6) 12.9 15.7 14.5 Net Cash/(Debt) 3,889 3,419 5,463 12,723
Page 63
China Dairy Sector
H&H International
Bloomberg: 1112 HK Equity | Reuters: 1112.HK Refer to important disclosures at the end of this report
20.8
70 nutrition might be mildly impacted by a change in stock
50
10.8 30 discounting structure implemented in 4Q16. Though consensus
Jul-13 Jul-14 Jul-15 Jul-16 Jul-17
expects an earnings decline in FY17F, valuation appears
H & H International (LHS) Relative HSI (RHS)
undemanding at 15x FY18F PE (based on consensus estimates),
Forecasts and Valuation versus its 5-year average of 23.7x.
F Y D ec ( R M B m) 2013A 2014A 2015A 2016A
Turnov er 4,561 4,732 4,819 6,506
EBITDA 1,261 1,150 627 1,949 Infant formula top-line recovery on pick-up in inventory level.
Pre-tax Profit 1,162 1,118 503 1,457
With stricter formula registration rules, competition and price
Net Profit 821 807 251 954
Net Pft (Pre Ex.) 821 807 251 954 risk were high in FY16 as players sought to reduce the number
EPS (RMB) 1.37 1.34 0.41 1.52 of product series offerings. Biostime reported a 3.7% y-o-y
EPS (HK$) 1.59 1.55 0.48 1.76 decline in FY16 baby and nutrition care (BNC) sales, dragged by
EPS Gth (%) 10.5 (2.2) (69.4) 270.7
Diluted EPS (HK$) 1.34 1.31 0.40 1.50
mid-tier Adimil brand, while Biostime brand rose 4.4% y-o-y.
DPS (HK$) 1.11 0.61 - - The company also launched an organic brand, Healthy Times
BV Per Share (HK$) 4.84 5.57 6.06 5.81 (acquired in July 2015), to capture the growing demand for
PE (X) 15.1 15.4 50.3 13.6 organic products. We expect inventory to resume healthier
P/Cash F low (X) 17.4 11.9 36.2 9.7
P/F ree CF (x) n.m. 30.0 296.9 10.3
levels in FY17 after cautiousness in the cross-border e-
EV /EBITDA (X) 9.1 10.0 30.5 9.3 commerce positive list announcement in April’16. In fact, H&H
Net Div Yield (%) 4.7 2.6 - - reported sales increase of 9% y-o-y from super premium and
P/Book V alue (X) 4.9 4.3 3.9 4.1 premium products, while baby nutrition and care sales rose
Net Debt/Equity (X) Cash Cash 1.9 1.7
ROA E (%) 33.9 29.7 8.1 29.6
10.8% y-o-y, driven by volume in 1Q17. The company has
already filed its CFDA registration and is now awaiting approval.
ICB Industry: Consumer Goods
ICB Sector: Food Producers At A Glance
Principal Business: One of the top infant formula companies in China Issued Capital (m shrs) 633
under Biostime and Adimil Mkt. Cap (HK$m/US$m) 15,104 / 1,934
Source of all data on this page: Company, DBSV, Thomson Reuters, Major Shareholders
HKEX Biostime Pharmaceuticals (China) Limited (%) 71.6
Free Float (%) 28.4
3m Avg. Daily Val. (US$m) 4.6
Page 64
ed-TH / sa- DL
DBSV's discussion of the issuer in this report will not be continuously followed. Accordingly, this report is being provided as a stand-alone analysis and recipients of this report should not expect
additional reports relating to this issuer, unless so decided by DBSV
China Dairy Sector
H&H International
Adult nutrition and care. H&H paid RMB6.5bn for an 83% Quick solutions. To overcome the long registration period for
stake in Swisse (c.13x FY15 EBITDA), with the remaining 17% each SKU, H&H began to roll out certain offline products in
stake held by its founder. The deal was funded by new shares selected retail outlets such as Watsons and Sam’s clubs. These
(20.5m shares at HK$13.48/share) and a series of debt products pass off as normal goods (e.g. Hero products Hair,
issuances (HK$3.1bn convertible bonds due 2019). Swisse is the Skin and Nails, and Cranberry Concentrate) and help to balance
no. 1 nutrition brand in the healthcare category in both Tmall the company's overall channel mix.
and Taobao. In 1Q17, adult nutrition sales declined 0.5% on
tightening of discount policy, and higher base on regulatory
changes on CBEC. With the pending collaboration agreement on China, the
market expects P&G to allow H&H to operate and take up the
royalty fee. This reduces the operating risks for P&G in the long
The sector faces a few key issues: run. In May, the company derived a 4-year sales and marketing
investment plan to expand sales in Swisse adult nutrition which
will result in a significant jump in sales, marketing, distribution
(1) Cross-border e-commerce regulation, which was and other operating expenses. Compared with peers,
announced in April 2016, stipulated Positive Lists of items Herbalife's 5-year SG&A expense-to-sales was at c.38%, versus
which are exempted from an import license, while H&H's 35.5% in FY16.
products (infant formula and nutrition supplements)
under CFDA rules will require registration prior to import.
Improving operating leverage to partly offset increase in raw
Administrative Measures for Registration and Filing of
material costs. H&H’s cost of sales comprises mainly milk
Health Food requires filing for certain imported
powder and packaging materials, whose prices are mostly on
vitamin and mineral supplements using approved raw
an uptrend y-o-y. That being said, improving infant formula
materials. The sector is waiting for supporting rules to
volumes should have some operating leverage to offset the
be fully released, following which the company will
increase in raw material prices.
commence the filing and registration procedures for
certain products.
Net gearing exceeds 100%. With the acquisition of the
remaining 17% equity interest in Swisse for AUD311m (or
(2) The company is tied to a Collaboration Agreement where
RMB1.56bn), net gearing now exceeds 186%. In January 2017,
PGT Healthcare (P&G) has the right to develop markets
the company issued senior notes for US$200m which was used
for Swisse’s products globally, except for the markets of
to fund the acquisition of the remaining stake. Free cash flow
Australia, New Zealand, North America and Canada. The
turned positive in FY16, which suggests some support from
agreement also grants an option to either (i) transfer its
improving financial position.
China business to P&G and receive 50% of operating
profit as well as a fee of between 4-7.75% based on net
outside sales (NOS), or (ii) to operate in China and pay
Valuation discounted on regulatory risks, focus on top-line
P&G a royalty (4.75%) based on NOS achieved after
growth. H&H is trading at 15x FY18F PE, which is at a 37%
exercise date. The earliest time for this to take place will
discount to its 5-year trading average. In the long run, we
be September 2020 with a 12-month prior notice. As of
believe both segments command strong growth potential,
2016, Swisse sales within China accounted for 6% of
supported by industry-wide policy changes (2-child policy) and
total net sales.
health consciousness. We believe distributors have begun
restocking their inventory levels (previously cautious on the
CBEX regulation's Positive List) as seen in 1Q operating metrics.
Page 65
China Dairy Sector
H&H International
Income Statement (RMB m) Balance Sheet (RMB m)
FY D e c 2013A 2014A 2015A 2016A FY D e c 2013A 2014A 2015A 2016A
Re ve nue 4,561 4,732 4,819 6,506 Ne t Fixe d Asse ts 391 541 609 591
Cost of Goods Sold (1,586) (1,805) (1,834) (2,447) Invts in Assocs & JVs 41 40 35
Gr o s s P r o fi t 2 ,9 7 5 2 ,9 2 7 2 ,9 8 5 4 ,0 5 9 Othe r LT Asse ts 1,384 1,714 8,557 9,146
Othe r Opg (Exp)/Inc (1,741) (1,827) (2,446) (2,282) Ca sh & ST Invts 1,663 3,347 1,198 1,506
O p e r a t i n g P r o fi t 1 ,2 3 4 1 ,0 9 9 538 1 ,7 7 7 Inve ntory 972 797 856 775
Othe r Non Opg (Exp)/Inc (149) (8) 0 29 De btors 15 12 623 517
Associa te s & JV Inc 1 (0) (5) Othe r Curre nt Asse ts 216 179 1,961 1,634
Ne t Inte re st (Exp)/Inc 77 26 (35) (344) To t a l As s e t s 4 ,6 4 1 6 ,6 3 1 1 3 ,8 4 4 1 4 ,2 0 5
Exce ptiona l Ga in/(Loss) - - - -
P r e - t a x P r o fi t 1 ,1 6 2 1 ,1 1 8 503 1 ,4 5 7 ST De bt 751 4,740 1,974
Ta x (341) (312) (210) (405) Cre ditors 355 290 611 524
Minority Inte re st (42) (98) Othe r Curre nt Lia b 939 978 1,328 2,739
Pre fe re nce Divide nd - - - - LT De bt 2,411 2,659 4,785
N e t P r o fi t 821 807 251 954 Othe r LT Lia bilitie s 81 36 904 986
Ne t Profit be fore Exce pt. 821 807 251 954 Sha re holde r's Equity 2,516 2,917 3,293 3,162
EBITDA 1,261 1,150 627 1,949 Minority Inte re sts 309 35
Re ve nue Gth (%) 34.9 3.7 1.8 35.0 To t a l Ca p . & Li a b . 4 ,6 4 1 6 ,6 3 1 1 3 ,8 4 4 1 4 ,2 0 5
EBITDA Gth (%) 22.8 (8.8) (45.5) 211
Non-Ca sh Wkg. Ca p (91) (279) 1,501 (337)
Opg Profit Gth (%) 22.9 (10.9) (51.0) 230.0
Ne t Ca sh/(De bt) 912 937 (6,201) (5,253)
Effe ctive Ta x Ra te (%) 29.4 27.9 41.8 27.8
Cash Flow Statement (RMB m) Rates & Ratio
FY D e c 2013A 2014A 2015A 2016A FY D e c 2013A 2014A 2015A 2016A
Pre -Ta x Profit 1,162 1,118 503 1,457 Gross Ma rgin (%) 65.2 61.9 61.9 62.4
De p. & Amort. 27 51 88 172 Opg Profit Ma rgin (%) 27.1 23.2 11.2 27.3
Ta x Pa id (347) (338) (280) (401) Ne t Profit Ma rgin (%) 18.0 17.1 5.2 14.7
Assoc. & JV Inc/(loss) - (1) 0 5 ROAE (%) 33.9 29.7 8.1 29.6
(Pft)/ Loss on disposa l of FAs 0 2 0 8 ROA (%) 20.1 14.3 2.4 6.8
Non-Ca sh Wkg. Ca p. (167) 151 5 (236) ROCE (%) 29.0 18.2 3.7 11.4
Othe r Ope ra ting CF 36 58 31 331 Div Pa yout Ra tio (%) 75.8 61.1 78.2 n.m.
N e t O p e r a t i n g CF 7 1 1 1 ,0 4 1 3 4 8 1 ,3 3 6 Inte re st Cove r (x) n.a . n.a . 15.2 5.2
Ca pita l Exp. (ne t) (136) (135) (109) (84) Asse t Turnove r (x) 1.1 0.8 0.5 0.5
Othe r Invts. (ne t) (5) (403) (4,094) (801) De btors Turn (da ys) 0.6 1.1 24.0 32.0
Invts. in Assoc. & JV - - - - Cre ditors Turn (da ys) 71.0 65.2 89.6 84.7
Div from Assoc. & JV - - - - Inve ntory Turn (da ys) 172.0 178.9 164.5 121.7
Othe r Inve sting CF - - - - Curre nt Ra tio (x) 1.4 3.4 0.7 0.8
N e t I n ve s t i n g CF (1 4 0 ) (5 3 8 ) (4 ,2 0 3 ) (8 8 5 ) Quick Ra tio (x) 0.9 2.8 0.6 0.7
Div Pa id (622) (493) (196) - Ne t De bt/Equity (X) Ca sh Ca sh 1.9 1.7
Chg in Gross De bt 480 1,664 4,740 (1,261)
Ca pe x to De bt (%) 18.1 5.6 1.5 1.2
Ca pita l Issue s (64) 9 12 5
N. Ca sh/(De bt)PS (RMB) 1.51 1.54 (9.84) (8.33)
Othe r Fina ncing CF (1) (1) (2,033) 982
Opg CFPS (RMB) 1.19 1.73 0.57 2.13
N e t Fi n a n c i n g CF (2 0 7 ) 1 ,1 7 9 2 ,5 2 4 (2 7 4 )
Fre e CFPS (RMB) (0.08) 0.69 0.07 2.00
Chg in Ca sh 364 1,682 (1,332) 177
Interim Income Statement (RMB m) Segmental Breakdown (RMB m) / Key Assumptions
FY De c 1 H1 5 2 H1 5 1 H1 6 2 H1 6 FY D e c 2013A 2014A 2015A 2016A
Revenue 1,963 2,856 3,008 3,497 R e ve n u e s
Cost of Goods Sold (820) (1,014) (1,080) (1,366) Infa nt Formula 3,752 3,982 3,356 3,204
Gro s s Pro fi t 1 ,1 4 3 1 ,8 4 2 1 ,9 2 8 2 ,1 3 1 Adult Nutrition a nd Ca re
Other Oper. (Exp)/Inc (866) (1,580) (1,156) (1,126) - - 850 2,683
Products
O p e ra ti n g Pro fi t 277 261 772 1 ,0 0 5
Othe r Pe dia tric Products - - 613 619
Other Non Opg (Exp)/Inc (12) 12 22 4
Drie d Ba by Food Products 199 151 - -
Associates & JV Inc (0) (3)
Ba by Ca re Products 152 173 - -
Net Interest (Exp)/Inc 15 (50) (130) (214)
Probiotic Supple me nts 458 425 - -
Exceptional Gain/(Loss) - - - -
To t a l 4 ,5 6 1 4 ,7 3 2 4 ,8 1 9 6 ,5 0 6
Pre -ta x Pro fi t 280 223 662 795
Tax (75) (135) (257) (148)
Minority Interest (42) (48) (50)
Ne t Pro fi t 205 46 357 597
Net profit bef Except. 205 46 357 597
Page 66
China Dairy Sector
Yashili Int'l
Bloomberg: 1230 HK EQUITY | Reuters: 1230.HK Refer to important disclosures at the end of this report
Page 67
ed-TH / sa- DL
DBSV's discussion of the issuer in this report will not be continuously followed. Accordingly, this report is being provided as a stand-alone analysis and recipients of this report should not expect
additional reports relating to this issuer, unless so decided by DBSV
China Dairy Sector
Yashili Int'l
Infant formula FY13-16 sales declined at a CAGR of 23%, Margin trend (%)
underperforming nutrition sector which grew 14% over
the same period 60% 53% 51% 51%
47%
50%
4,500
40%
4,000
30%
3,500 546
20% 11%
3,000 9%
10% 4%
2,500 534 12%
757 0% 9%
2,000
3,321 668 -10% -1% -15%
1,500
2,271 -20%
1,000 1,992
1,462 -30% -20%
500 2013 2014 2015 2016
0 Gross margin Operating margin Net margin
2013 2014 2015 2016
Infant formula Nutrition
Source: Company data, DBS Vickers
Page 68
China Dairy Sector
Yashili Int'l
2,000
Inclusion of Dumex, &
1,800 Oushi Mengniu (incl. Arla)
369
1,600
349 No longer disclose
1,400 each brand's
305 292 performance
1,200 274
1,000
164
800 113 68
1,521 86 50
1,334 163
600 1,144 1,140
1,030 59
400 803 774 695 637
200 486
0
1H12 2H12 1H13 2H13 1H14 2H14 1H15 2H15 1H16 2H16
Infant formula Yashily Formula Scient Formula Oushi Mengniu Dumex Arla
Yashili timeline
Da te De s c rip tio n
Se p-13 Me ngniu Group e nte re d into stra te gic coope ra tion with Ya shili by wa y of ge ne ra l offe r a t HK$3.5/sh for HK$12.46bn,
e nding with a 75.3% sta ke .
Oct-14 Da none e nte rs into sha re subscription a gre e me nt for 25% sta ke from Me ngniu a t HK$3.7/sh for HK$3.49bn, with the
de a l close d in Fe b'15. Me ngniu's sta ke wa s subse que ntly re duce d to 51%
Nov-15 Ya shili e nte rs into a stra te gic coope ra tion supply a gre e me nt with Da none to supply ba se powde r products a nd da iry
ingre die nts.
Nov-15 Ne w Z e a la nd pla nt forma lly comme nce d production in Nov'15. The pla nt cost NZ $220m with 52,000 tonne s in
ca pa city.
De c-15 Ya shili a cquire s Me ngniu's infa nt formula pla tform, Oushi Me ngniu, for Rmb1,050m a nd officia lly be ca me the sole
milk powde r pla tform for Me ngniu. The de a l va lue d Oushi Me ngniu for 13.2x FY14 PE. The e ntity he ld 1 fa ctory in
He lin.
Ma y-16 Ya shili a cquire s Dume x China for EUR150m (HK$1,230m) for its sa le s cha nne ls in 1st-2nd tie r citie s, a s we ll a s re -
optimising re source s with its production fa cilitie s in Sha ngha i. Dume x China wa s loss-ma king a t the time .
Se p-16 Cha irma n Je ffre y Lu le a ve s Ya shili to be come Me ngniu's Cha irma n.
Ja n-17 Chopin Z ha ng joins a s the e xe cutive dire ctor a nd CEO of the Compa ny from Dume x China .
Brand offerings
Page 69
China Dairy Sector
Yashili Int'l
Page 70
Asian Insights SparX
China Dairy Sector
Appendix
Prices - corn Prices - alfalfa
Rmb/ton US$/ton
2,800 250
2,600
2,400 200
2,200
2,000 150
1,800
1,600 100
1,400
50
1,200
1,000
0
May/13
May/14
May/15
May/16
May/17
Sep/13
Sep/14
Sep/15
Sep/16
Jan/14
Jan/15
Jan/16
Jan/17
US$/ton RMB/ton
550 8,000
7,500
500
7,000
450 6,500
6,000
400
5,500
350 5,000
4,500
300
4,000
250 3,500
May/14
Oct/14
Feb/16
Mar/15
Sep/15
Jan/17
Dec/13
Jun/17
Jul/16
May/10
May/11
May/12
May/13
May/14
May/15
May/16
May/17
Nov/10
Nov/11
Nov/12
Nov/13
Nov/14
Nov/15
Nov/16
RMB/ton RMB/ton
13,000 18,000
12,500
12,000 16,000
11,500
11,000 14,000
10,500
10,000 12,000
9,500
9,000 10,000
8,500
8,000 8,000
Mar/17
Mar/17
Jan/16
Jan/17
Jan/16
Jan/17
Jan/14
Jan/15
Jan/14
Jan/15
Jun/17
Jun/17
Jul/16
Jul/16
Jul/14
Jul/15
Jul/14
Jul/15
Nov/13
Nov/13
Oct/16
Oct/16
Oct/14
Oct/15
Oct/14
Oct/15
Apr/16
Apr/16
Apr/14
Apr/15
Apr/14
Apr/15
2010
2011
2012
2013
2014
2015
2016
0%
2012 2014 2016 2018F 2020F
World APAC China Top 3 Premium UHT Milk Brands UHT Milk
China Shengmu
Modern Dairy 1.7%
2.8% Nestle
16%
Bright Dairy
1.0%
Japfa Danone
1.0% 8%
100% 100%
90% 90%
80% 38.5% 38.2% 80% 39.4% 41.7%
70% 70%
60% 8.5% 7.6% 60%
50% 50% 15.3% 15.6%
40% 25.7% 26.8% 40%
16.9% 15.1%
30% 30%
20% 20%
27.3% 27.4% 28.4% 27.6%
10% 10%
0% 0%
2015 2016 2015 2016
Mengniu Yili Bright Dairy Others Mengniu Yili Bright Dairy Others
100%
90%
32.5% 32.4%
80%
70%
9.9% 8.4%
60%
50%
30.0% 31.3%
40%
30%
20%
27.6% 27.9%
10%
0%
2015 2016
Mengniu Yili Bright Dairy Others
No. Count ry M anuf ac t ure name No. Count ry M anuf ac t ure name
1 Singapore Wy eth Nutritionals 35 F rance COOPERATIV E ISIGNYSAINTE MERE
CELIA-LAITERIE DE
2 Singapore Abbott Manufacturing 36 F rance
CRAON
Py eongtaek factory , Maeil Dairies
3 Korea 37 F rance LACTINOV ABBEV ILLE
Co.,Ltd
4 Korea LOTTE F OODS CO 38 F rance NUTRIBIO
LAITERIE DE MONTAIGU SAS
5 Korea Namy ang Dairy Products 39 F rance
SABOURIN
Samy ang Packaging Corporation
6 Korea 40 F rance UNION LAITIERE V ENISE V ERTE
Kwanghaewon Plant
7 Korea Ildong F oodis Chuncheon Plant 41 F rance EV EN SANTE INDUSTRIE
8 New Zealand Nutricia Limited 42 F rance SYNUTRA F rance International SAS
9 New Zealand NIG Nutritionals 43 Germany Töpfer GmbH
10 New Zealand Canpac International 44 Germany Nestlé Deutschland AG
11 New Zealand Sy nlait Milk 45 Germany Milupa GmbH
Milchwirtschaftliche Industrie
12 New Zealand Blue Riv er Dairy LP 46 Germany
Gesellschaft Herford GmbH & Co. KG
13 New Zealand Sutton Group 47 Germany CREMILK GmbH
14 New Zealand Dairy Goat Co-operativ e 48 Ireland Kerry Ingredients (Ireland)
15 New Zealand New Zealand New Milk 49 Ireland Abbott Ireland
16 New Zealand Yashili New Zealand Dairy 50 Ireland Wy eth Nutritionals Ireland
17 New Zealand GMP Dairy Limited 51 Ireland Nutricia Infant Nutrition
18 New Zealand Alpha Laboratories (NZ) 52 Italy GRANAROLO S.P.A
19 New Zealand Health Pak 53 Holland MEAD J OHNSON B.V
20 New Zealand New Zealand Pure Dairy 54 Holland NESTLE NEDERLAND
Camperdown Powder (export
21 Australia 55 Holland F rieslandCampina Domo
license suspeneded)
22 Australia V IPLUS DAIRY 56 Holland ABBOTT LABORATORIES
23 Australia SPHERE HEALTHCARE 57 Holland Ly pack Leeuwarden B.V .
24 Australia F ARMLAND DAIRY PTY 58 Holland Nutricia Cuijk B.V .
25 Australia asis 59 Holland Industriële Diensten Heino
26 Australia TATURA MILK INDUSTRIES 60 Poland GEO-POLAND SP.
27 Australia MURRAY GOULBURN 61 Switzerland HOCHDORF Swiss Nutrition Ltd.
28 Australia BLEND AND PACK 62 Switzerland HOCHDORF Swiss Nutrition Ltd.
29 Austria Agrana Stärke GmbH 63 Switzerland Nestlé Suisse S.A.
Pöll Beteiligungs GmbH & CO.KG- INDUSTRIAS LACTEAS
30 Austria 64 Spain
Gittis Naturprodukte ASTURIANAS,S.A.
31 Belgium Belgomilk CV BA 65 Spain ALTER F ARMACIA, S.A.
32 Denmark Arla F oods amba Arinco 66 Spain ABBOTT LABORATORIES S.A.
Arla F oods amba Esbjerg
33 Denmark 67 Spain HERO ESPAÑA, S.A.
Mejeri Dairy
V olkov y sk Open J oint
34 United Kingdom Kendal Nutricare Ltd 68 Belarus
Stock Company «Bellakt »
Upstream sector
Downstream Operators
20 1 3 2 01 4 2 0 15 2016
Co n so lid at ed sales ( R M B m)
Mengniu 43,357 50,049 49,027 53,779
Bright 16,290 20,650 19,373 20,207
Yili 47,779 54,436 59,515 60,609
G ro ss p ro f it (R mb m)
Mengniu 11,697 15,434 15,375 17,635
Bright 5,576 6,972 6,899 7,697
Yili 13,462 17,851 21,733 22,885
G ro ss marg in (% )
Mengniu 27.0 30.8 31.4 32.8
Bright 34.2 33.8 35.6 38.1
Yili 28.2 32.8 36.5 37.8
S&D ex penses ( R mb m)
Mengniu (8,168) (10,564) (10,985) (13,435)
Bright (4,410) (5,471) (5,392) (5,619)
Yili (8,546) (10,075) (13,258) (14,114)
A d min ex pen se (R mb m)
Mengniu (1,606) (1,941) (1,871) (2,471)
Bright (484) (585) (683) (772)
Yili (2,392) (3,163) (3,456) (3,457)
SG &A (% )
Mengniu 22.5 25.0 26.2 29.6
Bright 30.0 29.3 31.4 31.6
Yili 22.9 24.3 28.1 29.0
O p erat in g marg in (% )
Mengniu 4.27 5.32 5.40 (0.78)
Bright 4.17 3.75 4.17 6.26
Yili 5.50 8.35 8.60 9.15
Net p ro f it ( R mb m)
Mengniu 1,631 2,351 2,367 (751)
Bright 406 570 418 563
Yili 3,187 4,144 4,632 5,662
Net g earin g (x )
Mengniu 26% 24% 14% 12%
Bright Net cash Net cash Net cash Net cash
Yili Net cash 12% Net cash Net cash
CA PEX
Mengniu (2,867) (2,931) (3,043) (3,268)
Bright (3,241) (3,946) (3,652) (3,419)
Yili (1,195) (1,797) (2,166) (1,290)
O CF
Mengniu 3,284 3,080 1,909 4,513
Bright 5,475 2,436 9,536 9,536
Yili 1,305 338 1,866 2,609
- Acquired Uncle
Established JV Toby’s in 2006, an - Acquired
Nutrition & Founded Nestle Launched baby with General Australian breakfast Wyeth in 2012
He alth by Henri Nestle rice cereal Mills in 1991,
cereal producer - Acquired US-
Ca re in 1867, selling “Cerelac” in selling - Acquired Gerber based Pamlab
P r oducts baby food 1954 breakfast
in 2007 from in 2013
cereal products Novartis
Acquired - Acquired
Germany Swiss brand
Merged with Acquired Egron Acquired US- Acquired
based Jopa and Frisco in 1962
Anglo-Swiss in 1916, a based Movenpick &
Da iry & Ice Condensed Norway-based French brand - Acquired Carnation in Dreyer’s in 2003
Cr eam Heudebert- Chambourcy in
Milk Company dairy company 1985
in 1905 Gervals in 1968, a French
1960 yogurt
producer
Acquired - Acquired frozen food - Acquired frozen food
Alimentana in Acquired company Stouffer in business from Chef
P repared 1947, a company frozen food 1973 America in 2003
F ood & with major company - Acquired canned - Acquired frozen pizza
F lavourings products of soup Findus in 1962 food company McNeill business from Kraft in
& flavourings & Libby in 1976 2010
Fresh Milk
UHT milk
Yogurt
Milk Powder
Butter / Cheese
Source: Company
Ice-cream
Milk Beverage
Milk powder
UHT Milk
Yogurt
Source: Company
Ice Cream
Innovative
Milk beverage
UHT Milk
Milk Powder
Yogurt
Source: Company
DBSVHK recommendations are based an Absolute Total Return* Rating system, defined as follows:
STRONG BUY (>20% total return over the next 3 months, with identifiable share price catalysts within this time frame)
BUY (>15% total return over the next 12 months for small caps, >10% for large caps)
HOLD (-10% to +15% total return over the next 12 months for small caps, -10% to +10% for large caps)
FULLY VALUED (negative total return i.e. > -10% over the next 12 months)
SELL (negative total return of > -20% over the next 3 months, with identifiable catalysts within this time frame)
Sources for all charts and tables are DBS Vickers unless otherwise specified.
GENERAL DISCLOSURE/DISCLAIMER
This report is prepared by DBS Vickers (Hong Kong) Limited (“DBSV HK”). This report is solely intended for the clients of DBS Bank Ltd., DBS Bank
(Hong Kong) Limited (DBS HK), DBSV HK, and DBS Vickers Securities (Singapore) Pte Ltd. (“DBSVS”), its respective connected and associated
corporations and affiliates only and no part of this document may be (i) copied, photocopied or duplicated in any form or by any means or (ii)
redistributed without the prior written consent of DBSV HK.
The research set out in this report is based on information obtained from sources believed to be reliable, but we (which collectively refers to DBS
Bank Ltd., DBS HK, DBSV HK, DBSVS, its respective connected and associated corporations, affiliates and their respective directors, officers,
employees and agents (collectively, the “DBS Group”) have not conducted due diligence on any of the companies, verified any information or
sources or taken into account any other factors which we may consider to be relevant or appropriate in preparing the research. Accordingly, we
do not make any representation or warranty as to the accuracy, completeness or correctness of the research set out in this report. Opinions
expressed are subject to change without notice. This research is prepared for general circulation. Any recommendation contained in this document
does not have regard to the specific investment objectives, financial situation and the particular needs of any specific addressee. This document is
for the information of addressees only and is not to be taken in substitution for the exercise of judgement by addressees, who should obtain
separate independent legal or financial advice. The DBS Group accepts no liability whatsoever for any direct, indirect and/or consequential loss
(including any claims for loss of profit) arising from any use of and/or reliance upon this document and/or further communication given in relation
to this document. This document is not to be construed as an offer or a solicitation of an offer to buy or sell any securities. The DBS Group, along
with its affiliates and/or persons associated with any of them may from time to time have interests in the securities mentioned in this document.
The DBS Group, may have positions in, and may effect transactions in securities mentioned herein and may also perform or seek to perform
broking, investment banking and other banking services for these companies.
Any valuations, opinions, estimates, forecasts, ratings or risk assessments herein constitutes a judgment as of the date of this report, and there can
be no assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk assessments.
The information in this document is subject to change without notice, its accuracy is not guaranteed, it may be incomplete or condensed, it may
not contain all material information concerning the company (or companies) referred to in this report and the DBS Group is under no obligation to
update the information in this report.
This publication has not been reviewed or authorized by any regulatory authority in Singapore, Hong Kong or elsewhere. There is no planned
schedule or frequency for updating research publication relating to any issuer.
The valuations, opinions, estimates, forecasts, ratings or risk assessments described in this report were based upon a number of estimates and
assumptions and are inherently subject to significant uncertainties and contingencies. It can be expected that one or more of the estimates on
which the valuations, opinions, estimates, forecasts, ratings or risk assessments were based will not materialize or will vary significantly from actual
results. Therefore, the inclusion of the valuations, opinions, estimates, forecasts, ratings or risk assessments described herein IS NOT TO BE RELIED
UPON as a representation and/or warranty by the DBS Group (and/or any persons associated with the aforesaid entities), that:
(a) such valuations, opinions, estimates, forecasts, ratings or risk assessments or their underlying assumptions will be achieved, and
(b) there is any assurance that future results or events will be consistent with any such valuations, opinions, estimates, forecasts, ratings or risk
assessments stated therein.
Please contact the primary analyst for valuation methodologies and assumptions associated with the covered companies or price targets.
Any assumptions made in this report that refers to commodities, are for the purposes of making forecasts for the company (or companies)
mentioned herein. They are not to be construed as recommendations to trade in the physical commodity or in the futures contract relating to the
commodity referred to in this report.
DBSVUSA, a US-registered broker-dealer, does not have its own investment banking or research department, has not participated in any public
offering of securities as a manager or co-manager or in any other investment banking transaction in the past twelve months and does not engage
in market-making.
ANALYST CERTIFICATION
The research analyst(s) primarily responsible for the content of this research report, in part or in whole, certifies that the views about the
companies and their securities expressed in this report accurately reflect his/her personal views. The analyst(s) also certifies that no part of his/her
compensation was, is, or will be, directly or indirectly, related to specific recommendations or views expressed in the report. The research analyst (s)
1
primarily responsible for the content of this research report, in part or in whole, certifies that he or his associate does not serve as an officer of
the issuer or the new listing applicant (which includes in the case of a real estate investment trust, an officer of the management company of the
real estate investment trust; and in the case of any other entity, an officer or its equivalent counterparty of the entity who is responsible for the
management of the issuer or the new listing applicant) and the research analyst(s) primarily responsible for the content of this research report or
2
his associate does not have financial interests in relation to an issuer or a new listing applicant that the analyst reviews. DBS Group has
procedures in place to eliminate, avoid and manage any potential conflicts of interests that may arise in connection with the production of
research reports. The research analyst(s) responsible for this report operates as part of a separate and independent team to the investment
banking function of the DBS Group and procedures are in place to ensure that confidential information held by either the research or investment
banking function is handled appropriately. There is no direct link of DBS Group's compensation to any specific investment banking function of the
DBS Group.
2. Neither DBS Bank Ltd, DBS HK nor DBSV HK market makes in equity securities of the issuer(s) or company(ies) mentioned in this
Research Report.
DBS Bank Ltd, DBS HK, DBSVS, DBSV HK, their subsidiaries and/or other affiliates of DBSVUSA, within the next 3 months, will receive
or intend to seek compensation for investment banking services from China Merchants Port Holdings Company Limited (144 HK) as of
30 Jun 2017.
4. DBS Bank Ltd, DBS HK, DBSVS, DBSV HK, their subsidiaries and/or other affiliates of DBSVUSA have managed or co-managed a public
offering of securities for China Mengniu Dairy Company Limited (2319 HK), Japfa Comfeed Indonesia (JPFA IJ) and COFCO Meat
Holdings Limited (1610 HK) in the past 12 months, as of 30 Jun 2017.
DBSVUSA does not have its own investment banking or research department, nor has it participated in any public offering of securities
as a manager or co-manager or in any other investment banking transaction in the past twelve months. Any US persons wishing to
obtain further information, including any clarification on disclosures in this disclaimer, or to effect a transaction in any security
discussed in this document should contact DBSVUSA exclusively.
1
An associate is defined as (i) the spouse, or any minor child (natural or adopted) or minor step-child, of the analyst; (ii) the trustee of a trust of
which the analyst, his spouse, minor child (natural or adopted) or minor step-child, is a beneficiary or discretionary object; or (iii) another person
accustomed or obliged to act in accordance with the directions or instructions of the analyst.
2
Financial interest is defined as interests that are commonly known financial interest, such as investment in the securities in respect of an issuer or
a new listing applicant, or financial accommodation arrangement between the issuer or the new listing applicant and the firm or analysis. This
term does not include commercial lending conducted at arm's length, or investments in any collective investment scheme other than an issuer or
new listing applicant notwithstanding the fact that the scheme has investments in securities in respect of an issuer or a new listing applicant.
RESTRICTIONS ON DISTRIBUTION
General This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident of or
located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be
contrary to law or regulation.
Australia This report is being distributed in Australia by DBS Bank Ltd. (“DBS”) or DBS Vickers Securities (Singapore) Pte Ltd
(“DBSVS”). DBS holds Australian Financial Services Licence no. 475946.
DBSVS is exempted from the requirement to hold an Australian Financial Services Licence under the Corporation Act 2001
(“CA”) in respect of financial services provided to the recipients. Both DBS and DBSVS are regulated by the Monetary
Authority of Singapore under the laws of Singapore, and DBSVHK is regulated by the Securities and Futures Commission of
Hong Kong under the laws of Hong Kong, which differ from Australian laws.
Distribution of this report is intended only for “wholesale investors” within the meaning of the CA.
Hong Kong This report is being distributed in Hong Kong by DBS Bank Ltd, DBS Bank (Hong Kong) Limited and DBS Vickers (Hong Kong)
Limited, all of which are registered with or licensed by the Hong Kong Securities and Futures Commission to carry out the
regulated activity of advising on securities.
Indonesia This report is being distributed in Indonesia by PT DBS Vickers Sekuritas Indonesia.
Malaysia This report is distributed in Malaysia by AllianceDBS Research Sdn Bhd ("ADBSR"). Recipients of this report, received from
ADBSR are to contact the undersigned at 603-2604 3333 in respect of any matters arising from or in connection with this
report. In addition to the General Disclosure/Disclaimer found at the preceding page, recipients of this report are advised
that ADBSR (the preparer of this report), its holding company Alliance Investment Bank Berhad, their respective connected
and associated corporations, affiliates, their directors, officers, employees, agents and parties related or associated with any
of them may have positions in, and may effect transactions in the securities mentioned herein and may also perform or seek
to perform broking, investment banking/corporate advisory and other services for the subject companies. They may also
have received compensation and/or seek to obtain compensation for broking, investment banking/corporate advisory and
other services from the subject companies.
United States This report was prepared by DBSVHK. DBSVUSA did not participate in its preparation. The research analyst(s) named on
this report are not registered as research analysts with FINRA and are not associated persons of DBSVUSA. The research
analyst(s) are not subject to FINRA Rule 2241 restrictions on analyst compensation, communications with a subject company,
public appearances and trading securities held by a research analyst. This report is being distributed in the United States by
DBSVUSA, which accepts responsibility for its contents. This report may only be distributed to Major U.S. Institutional
Investors (as defined in SEC Rule 15a-6) and to such other institutional investors and qualified persons as DBSVUSA may
authorize. Any U.S. person receiving this report who wishes to effect transactions in any securities referred to herein should
contact DBSVUSA directly and not its affiliate.
Other In any other jurisdictions, except if otherwise restricted by laws or regulations, this report is intended only for qualified,
jurisdictions professional, institutional or sophisticated investors as defined in the laws and regulations of such jurisdictions.
DBS Vickers (Hong Kong) Limited
th
18 Floor Man Yee building, 68 Des Voeux Road Central, Central, Hong Kong
Tel: (852) 2820-4888, Fax: (852) 2868-1523
Company Regn. No. 31758
As i a n E q u i t i e s S a l e s , S a l e s Tr a d i n g a n d R e s e a r c h Co n t a c t s
Sa le s He a d s Te l : E ma i l :
Singa pore Ke nne th Ta ng 65-6398 6951 ke nne thta ng@ dbsvic ke rs.c om
Hong Kong Andre w Au 852-2820 4992 a ndre wa u@dbs.c om
Hong Kong Christy La m 852-2971-1939 c hristy_la m@dbs.c om
London Gra ha m Booth 44-20-7618 1881 gra ha mbooth@dbs.c om
Ne w York Ela ine Yu 1-212-826 3553 e la ine yu@ us.dbsvic ke rs.c om
Tha ila nd Na risa ra Vise skosin 662-657 7759 Na risa ra V@ th.dbsvic ke rs.c om
Indone sia Ric a rdo Sila e n, CFA 6221 3003 4911 ric a rdo.sila e n@ id.dbsvic ke rs.c om
S a l e s Tr a d i n g Co n t a c t s Te l : E ma i l :
Singa pore Vivia n Goh 65-6398 6927 vivia ngohkb@ dbsvic ke rs.c om
Hong Kong Fra nco La w 852-2971 1828 fra nco_la w@dbs.c om
London Cha rle s Da vie s 44-20-7618 1883 c ha rle sda vie s@dbs.c om
Ne w York Bre nda Wong 1-212-826 3558 bre nda wong@ us.dbsvic ke rs.c om
R e s e a r c h Co n t a c t s Te l : E ma i l :
Re giona l Timothy Wong 65-6682 3691 timothywong@dbs.c om
Singa pore Ja nice Chua 65-6682 3692 ja nic e c hua st@dbs.c om
Hong Kong Ca rol Wu 852-2863 8841 c a rol_wu@dbs.c om
M a la ysia Wong M ing Te k 603-2604 3970 mingte k@ a llia nce dbs.c om
Tha ila nd Cha npe n Siritha na ra tta na kul 662-657 7824 c ha npe n@ th.dbsvic ke rs.c om
Indone sia M a yna rd Pria ja ya Arif 6221 3003 4930 ma yna rd.a rif@ id.dbsvic ke rs.c om
HO NG K O NG M A L A Y SIA SIN G A PO R E
DBS V ickers (Hong Kong) Ltd A llianceDBS Research Sdn Bhd DBS Bank Ltd
18th F loor Man Yee Building 19th F loor, Menara Multi-Purpose 12 Marina Boulev ard
68 Des V oeux Road Central Capital Square, 8 J alan Munshi A bdullah Lev el 40
Central, Hong Kong 50100 Kuala Lumpur Marina Bay F inancial Centre
Tel: 852-2820 4888 Tel: 603 2604 3333 Tow er 3, Singapore 018982
F ax: 852-2868 1523 F ax: 603 2604 3921 Tel: 65-6878 8888
Participant of The Stock Exchange
of Hong Kong Limited
IN D O N ESIA U N IT ED ST A T ES U N IT ED K IN G D O M
PT DBS V ickers Securities (Indonesia) DBS V ickers Securities (USA ) Inc DBS V ickers Securities (UK) Ltd
DBS Bank Tow er 777 Third A v enue 4th F loor Paternoster House
Ciputra World 1, 32/F Suite 26A 65 St Paul's Churchy ard
J l. Prof. Dr. Satrio Kav . 3-5 New York, New York 10017 London EC4M 8A B
J akarta 12940, Indonesia Tel: 1-212-826 1888 Tel: 44-20-7618 1888
Tel: 62-21- 3003 4900 F ax: 1-212-826 8704 F ax: 44-20-7618 1900
F ax: 62-21- 3003 4943 Member of F INRA and SIPC Regulated by The F inancial Serv ices A uthority
T H A IL A N D
DBS V ickers Securities (Thailand) Co, Ltd
989 Siam Piwat Tow er Building,
9th, 14th-15th F loor,
Rama 1 Road, Pathumwan,
Bangkok Thailand 10330
Tel. 66 2 657 7831
F ax: 66 2 658 1269